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CELLULAR PROLIFERATION, DEATH, AND HISTOLOGY IN
GAMBUSIA AFFINIS LIVERS AFTER EXPOSURE TO
2-AMINOFLUORENE AND BENDIZINE

Susan J. Lentz, Ph.D.
Western Michigan University, 2003

A fundamental need exists for aquatic animals in the biomonitoring of aquatic
ecosystems for environmental carcinogens. G. affinis, a small fish species, is selected for
this study due to its hardiness, non-migratory nature, geographic diversity and ability to
develop tumors. Molecular tools for cellular proliferation and death are examined for use
with G. affinis. Additionally, these tools are used to investigate the early carcinogenic
effects o f 2-aminofluorene and benzidine, both individually and combined, on G. affinis
livers.
Antibodies to proliferating cell nuclear antigen (PCNA), p53, cleaved caspase-3
and cleaved poly(ADP-ribose) polymerase (PARP) were examined for use in G. affinis.
While p53 and cleaved caspase-3 and PARP results were inconclusive, PCNA was
successful in detecting cellular proliferation in G. affinis. Additionally, the terminal
deoxynucleotidyl transferase-mediated dUTP-biotin neck end labeling (TUNEL) method
was examined and found to be a successful indicator o f cell death.
Therefore, cellular proliferation, death, and their difference in G. affinis livers
were assayed after dietary exposure to 0.069 mM and 6.9 mM doses of 2AF, BZ and
2AF/BZ for 4, 8 and 12 weeks. Hematoxylin and eosin (H&E) staining was used for
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histological examination. All treatment groups had similar responses at differing
degrees. These results from G. affinis exposure to 2AF, BZ and 2AF/BA indicate:
•

A transient increase in cellular death at 4 weeks that decreased at 8 and 12
weeks, some below control levels.

•

A substantial increase in cellular proliferation throughout the 4, 8 and 12
exposures above control levels.

•

A net increase in cellular growth above control levels.

•

Increases in oval cell proliferation, altered foci and tumor development.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

UMI N um ber: 3090925

UMI
UMI Microform 3090925
Copyright 2003 by ProQuest Information and Learning Company.
All rights reserved. This microform edition is protected against
unauthorized copying under Title 17, United States Code.

ProQuest Information and Learning Company
300 North Zeeb Road
P.O. Box 1346
Ann Arbor, Ml 48106-1346

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Copyright by
Susan J. Lentz
2003

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

ACKNOWLEDGMENTS

First and foremost, I would like to thank Dr. Anna Jelaso for her technical
expertise, patience, and friendship for they were invaluable in the completion o f my
research and writing o f this dissertation. I would also like to thank my graduate
committee chair, Dr. Jay Means, for his technical and financial support, along with my
graduate committee members, Dr. Charles Ide, Dr. Robert Eversole and Dr. Robert
Buck for their time in assisting me in the preparation of and in reviewing my
dissertation. Lastly, I would like to thank Dr. J. M. Law ofNorth Carolina State
University for sharing his expertise in G. affinis livers.

Susan J. Lentz

ii

Reproduced with permission o f the copyright owner. Further reproduction prohibited without permission.

TABLE OF CONTENTS

ACKNOWLEDGMENTS

............................................

LIST OF TABLES.....

............................................

ii
iv

LIST OF FIGURES.............................................................. ...........................

v

CHAPTER
I.

INTRODUCTION

...........................
......................

Cancer and Environmental Carcinogens

Polycyclic Arylamines............................ ...................................
Small Fish in Carcinogenic Studies

1
3

....................

Scope o f Dissertation...................................... ...................... ......
II. LITERATURE REVIEW....

..................

6
7

Carcinogenesis.............. ..............................................................

7
7

A Historical Overview..............................
Cellular Origins o f Cancer.....

4

..........

10

From Totipotent Stem Cells to Differentiated
Tissue Cells.............................................
Embryonal Theory of Cancer...

........................

11
12

Dedifferentiation of Mature Cells in the Origin of
Cancer
...................................
Maturation Arrest o f Stem Cell Differentiation in
the Origin o f Cancer
................................
Stages o f Carcinogenesis

..............................

iii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

13

14
16

Table of Contents—continued

Initiation

..........

17

Promotion.............

17

Progression

18

..............

Contributing Factors to the Genesis of Cancer..
Oncogenes

........

.............

20

Tumor Suppressor Genes

................

Environmental Contributors and Biotransformation.
Progress and Prevention..
The Cell Cycle

.............

22
23
24

............

26

Proliferation Cell Nuclear Antigen.....................

28

p53 Tumor Suppressor Gene.................

30

...........

Caspase-3

33

Poly (ADP-Ribose) Polymerase

............

35

Detection ofDNA Fragmentation During Cell Death

38

Benzidine

43

............

2-Aminofluorene.

.......

47

Gambusia Affinis

.........

50

Aquatic Species in Carcinogenic Studies..

......

Gambusia Affinis in Environmental Carcinogenesis
Studies ...............
III.

19

MOLECULAR TOOLS

......
iv

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

50

51
54

Table o f Contents—continued

Purpose of Investigating Molecular Tools

54

Experimental Design

55

.................

Methods and Materials ........

56

Fish and Housing...................

56

Flow Cytometry, Fluorescence Microscopy and
Differential Interference Contrast Microscopy
Cell Staining

.......

............

60
.................

61

Fluorescence Microscopy and DIC Microscopy

61

Western Blots for Immunodetection o f PCNA, p53,
......
Cleaved Caspase-3 and PARP Proteins

62

Flow Cytometry

Total Protein Extraction and Quantification

63

Western Blotting

63

............

Results..............................

65

Flow Cytometric Analysis o f AML21 Hepatocytes

65

Fluorescence Microscopy and DIC Microscopy of
AML12 Hepatocytes ............

66

Western Blots o f PCNA, p53, and Cleaved Caspase-3
and PARP...
........................

69

Discussion.........................
IV.

59

74

DETECTION OF CELLULAR PROLIFERATION AND DEATH
IN G. AFFINIS EXPOSED TO 2-AMINOFLUORENE AND
BENZIDINE.....
............

v

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

79

Table of Contents—continued

Purpose of Investigation................................................
Experimental Design
Methods and Materials
Fish and Housing

79

..........................

80

............................

82

........................

82

Tissue Sectioning of Livers..................................

83

PCNA Antibody and TUNEL Labeling of Tissue
Sections.....................................................

83

PCNA Antibody Labeling of Tissue Sections

84

TUNEL Labeling of Tissue Sections

85

......

Determination of PI Index and TUNEL Index
Results

......

PCNA Index..

87
...........................

87

.......

TUNEL Index

PCNA Index Minus TUNEL Index

89
.......................
........................

Discussion
Y.

85

101
103

HISTOPATHOLOGY OF 2-AMINOFLUORENE AND BENZIDINE
TREATED G. AFFINIS LIVERS
........................ .
111
Purpose of Study

................

Experimental Design

I ll

...................................

Methods and Materials

I ll
112

Results .................................................
Discussion..........................................................
vi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

116

Table o f Contents—continued

VI.

CONCLUSIONS

REFERENCES
APPENDICES

......

121

......

126

....................

174

A. Institutional Animal Care and Use Committee Approval form................

175

B. Individual TUNEL Index, PCNA Index and (PI - TI) Counts................

176

vii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF TABLES

1.

Experimental Design.......................

81

2.

Means for TUNEL Index, PCNA Index and Their Differences...................

90

3.

PCNA - Tests of Time and Treatment Effects and Interaction

95

4.

PCNA - Fisher’s Paired Least Significant Differences With Statistical
Significance
.......

96

TUNEL - Comparison o f Tests o f Treatment and Time Effects and
Interactions..............

99

TUNEL - Adjusted Comparison o f Treatment and Time Effects and
Interactions
.....

100

TUNEL - Fisher’s Paired Least Significant Differences With Statistical
Significance..................

100

PCNA and TUNEL Differences - Test o f Treatment and Time Effects
and Interaction
............

106

PCNA and TUNEL Differences - Fisher’s Paired Least Significant
Differences With Statistical Significance
.....................

106

Histopathological Examination o f G. Affinis Livers After Exposure to
2AF and BZ ........

114

5.
6.
7.
8
9.
10.

.........

viii

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

LIST OF FIGURES

1.

Schematic of the Cell Cycle........................................................

27

2. Dual Filtration System..........................

57

3. Circulating Air and Water Through CPVC Piping ......................................

58

4. Bulkhead Attachment for Continual Water Drainage.................

58

5

59

Filtration o f Drainage Water

...................

6. Flow Cytometry Histogram ofPropidium Iodide (PI) Stained
Freeze/Thawed AML12 Hepatocytes
......

67

7. Flow Cytometry Histogram ofPropidium Iodide (PI) Stained
Camptothecin Treated AML12 Hepatocytes............................

67

8. Flow Cytometry Histogram ofPropidium Iodide (PI) Stained Non.....
Treated AML12 Hepatocytes

68

9. Flow Cytometry Histogram ofHoechst 33342 Stained Camptothecin
Treated AML 12 Hepatocytes
................................

68

10.

Flow Cytometry Histogram ofHoechst 33342 Stained Non-Treated
AML12 Hepatocytes....................................

69

Western Blot of Anti-PCNA Antibody Labeling ofTotal Protein
Extracts
.........................................

72

12.

Western Blot o f Anti-p53 Antibody Labeling of Total Protein Extracts

72

13.

Western Blot of Anti-Cleaved Caspase-3 Antibody Labeling of Total
Protein Extracts.......................

73

Western Blot of Anti-Cleaved PARP Antibody Labeling o f Total
Protein Extracts
......

73

Histogram of PCNA Index Means and Standard Error for Treatment
Groups and Controls at 4 Weeks
............................................

91

11.

14.
15.

ix

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

List of Figures—continued

16.

Histogram of PCNA Index Means and Standard Error for Treatment
Groups and Controls at 8 Weeks....
....... ................. .............................

91

Histogram of PCNA Index Means and Standard Error for Treatment
Groups and Controls at 12 Weeks..
......... ............

91

Histogram of TUNEL Index Means and Standard Error for Treatment
Groups and Controls at 4 Weeks
.....................

92

Histogram of TUNEL Index Means and Standard Error for Treatment
Groups and Controls at 8 Weeks
..............

92

Histogram of TUNEL Index Means and Standard Error for Treatment
Groups and Controls at 12 Weeks.....................................

92

Histogram o f PI - TI Index Means and Standard Error for Treatment
Groups and Controls at 4 Weeks
......

93

Histogram of PI - TI Index Means and Standard Error for Treatment
Groups and Controls at 8 Weeks
........................

93

Histogram of PI - TI Index Means and Standard Error for Treatment
Groups and Controls at 12 Weeks.
.....

93

24.

PCNA Positives from a G. Affinis Liver Tissue Section..............

94

25.

PCNA Boxplot o f Wilcoxon Studentized Residuals...

94

26.

PCNA Q-Q Plot of Studentized Residuals

27.

TUNEL Positives from a G. Affinis Liver Tissue Section................

98

28.

TUNEL Boxplot o f Wilcoxon Studentized Residuals

98

29.

TUNEL Q-Q Plot o f Studentized Residuals.......................

30.

PCNA and TUNEL Differences Boxplot of Wilcoxon Studentized
Residuals
........................................

105

31.

PCNA and TUNEL Differences Q-Q Plot of Studentized Residuals. .......

105

32.

Altered Foci, Granuloma and PMA, Respectively, in G. Affinis Liver.........

117

17.
18.
19.
20.
21.
22.
23.

..................

.....

95

.........

x

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

99

List o f Figures—continued

33.

Basophilic Foci o f Spindle Cell Proliferation in G. Affinis Liver

xi

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER I
INTRODUCTION
Cancer and Environmental Carcinogens
Cancer has been around longer than civilization itself. It has been reported that
neoplastic lesions were observed by paleopathologists in the bones of dinosaurs [1].
Efforts to understand the genesis of cancer date back to the 4th century when Hippocrates’
put forth that excess black bile was the cause o f cancer. However, it wasn’t until 1838
that Johannes Muller observed that cancer tissue was made up of cells [2].
Epidemiologic research into cancer brought about a significant increase in knowledge of
human cancer causes after World War II including the relationship between human
cancer and environmental carcinogens [3]. Another significant increase in cancer
research was in the early 1970’s with the advent of recombinant DNA technology. That
technology led the advancement from animal models to molecular models [4]. Although
our understanding o f the processes involved in the onset and progression of cancer has
grown tremendously over the past 30 years, there is still no comprehensive picture of
carcinogenesis available today.
In broad terms, cancer is a complex, dynamic, and often, fatal disease in which
cells undergo molecular changes that lead to their uncontrolled proliferation. This
uncontrolled cellular proliferation lends itself to tumor formation that may or may not
become cancerous and metastasize. The underlying causes of cancer are attributed to
either or both genetic or epigenetic alterations [4-9]. Genetic origins are often due to
mutations in cancer related genes. These mutations are either germline (inherited) or

1
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somatic mutations (environmental) or a combination o f both. Viruses are also capable of
inducing cancer by integration o f their genome into the host cell [10]. While only a small
number of cancers are due to germline mutations, environmental components account for
about 80% to 90% of all cancers [3, 11,12].
With environmental carcinogenesis being a major factor in human cancers, great
effort has been made in elucidating the role these environmental carcinogens play in the
development and progression o f cancer. However, it is important to note that this is a
difficult task with more than 100 different cancers in more than 35 different organs and
tens o f thousands o f chemicals in the environment [5]. The environmental components
associated with carcinogenesis can either be localized, in cases such as improper disposal
o f industrial waste and run-off, or widely distributed, as with automobile exhaust
products and agriculture. World Health Organization data indicates that death rates due
to lung, breast, prostate, colon, rectal, stomach, and uterine cancers, are consistently
lowest in Thailand for both males and females. However, the highest death rates for
these same cancers are widely distributed across geographic regions according to sex and
cancer type indicating the geographic variation of environmental carcinogens that target
specific organs. In addition to the geographic distribution of environmental carcinogens,
variation exists in their concentration at different sites and their partitioning properties.
Additional culprits in environmental carcinogenesis are cultural, lifestyle, age, species,
and sex differences.
The study of environmental carcinogens is essential in understanding the
underlying events leading to the formation of cancer. While a great deal of knowledge
has been attained through scientific research regarding carcinogenesis, its relationship

2
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with environmental compounds is limited [13]. With over 50,000 chemicals registered
with the EPA and FDA, and more being continuously introduced, it is imperative to
understand the biological cellular mechanisms involved in environmental carcinogenesis.
With that understanding will come the ability to interfere with those mechanisms [14].
The National Institute o f Cancer (NIC) cites a special concern for products
originating from the combustion o f fossil fuels in diesel engines and automobile exhaust,
industrial emissions, residential and commercial space heating, and oil and coal fired
power plants. The byproducts o f these processes include polycyclic aromatic
hydrocarbons (PAH), polycyclic aromatic amines, and numerous other cancer related
compounds. While many o f these chemicals themselves may not directly initiate
carcinogenesis, their metabolites can initiate and promote the carcinogenic process. Thus
it is necessary to test these compounds in biological systems to determine their effects,
along with that o f their metabolites, on living organisms.

Polycyclic Arylamines

As previously stated, several o f the environmental pollutants listed for special
concern by the NIC contain PAH. Different processes (e.g. industrial, automotive) emit
different concentrations and types of PAH, o f which many are considered potent
carcinogens [15]. . The detrimental effects o f a wide range ofPAHs are well
documented. These effects include formation of DNA-adducts, sister chromatid
exchanges, lung, bladder and skin cancer, transplacental transfer, premature ovarian
failure, and activation o f the aromatic hydrocarbon receptors (AhR) [16-22]. Due to the

3
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numerous compounds that fall under the classification of PAH, it is only feasible to use
representative compounds for investigative inquiry.
There are two broad classes ofPAHs, the biaryls and the condensed benzenoid
hydrocarbons. These classes differ in whether their hydrocarbon ring structures are fused
(sharing two carbons) or linked (a single carbon bond). The representative class selected
here is the biaryls because they undergo electrophilic aromatic substitution more readily
than the condensed benzenoid hydrocarbons. This substitution occurs when one
electrophile (typically a proton) is replaced by another electron-deficient species [23].
The electrophilic amine groups o f polycyclic arylamines (PAA) are metabolized in the
liver to highly reactive nitrinium ions that bind DNA, forming DNA adducts [24].
The individual polycyclic arylamines chosen for this study are benzidine and 2aminofluorene. Both of these compounds and their metabolites are well studied and are
involved in carcinogenesis. Their effects on liver cells are of particular interest because
of the metabolic enzymes present in livers. These enzymes are capable o f either
metabolizing the compound to a less toxic form or a more toxic form. This paper
specifically examines the exposure of benzidine (BZ) and 2-aminofluorene (2AF) on
cellular proliferation, death, and growth in the livers o f the western mosquitofish, G.
affinis.

Small Fish in Carcinogenic Studies

Interest in the use o f fish models for environmental carcinogenesis studies has
grown as the need for more efficient animal models for statistical significance in cancer
research has also grown. An Interagency Agreement between the U.S. Army and the

4
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U.S. Environmental Protection Agency was initiated in the early 1980’s for the purpose
of developing more efficient animal models for evaluating the health effects of
environmental pollutants. It found development of fish models to be o f special interest in
carcinogenic studies [25]. The use o f fish in carcinogenic studies is growing due to the
similarities that fish have in their metabolic pathways with that o f mammals for
disposition of certain carcinogens [26]. Fish have also been demonstrated to form
neoplasms in short periods of time, are relatively easy to house and care for and due to
the small size o f numerous species, statistical significance can be more readily achieved
in an efficient manner [27-29],
Several fish models have been and are currently utilized in studies to demonstrate
the carcinogenic effects of chemical toxins [28-34]. These studies, along with numerous
others, indicate the feasibility o f small fish models in environmental carcinogenesis
studies. This study uses the western mosquitofish, Gambusia affinis. This fish is
ubiquitous in the United States, is non-migratory and is distributed throughout the globe
for mosquito control [35-37]. Thus, it can be monitored at numerous sites and is
representative of each site it resides. Additionally, they have been demonstrated to
develop neoplasms in response to chemical carcinogens [27]. Many of the other fish
species used in research are either exotic and reside in restricted waters, have low
tolerance of poor quality water, are migratory, or are large and not easily maintained.
Therefore, G. affinis has a promising future as both a sentinel species for biomonitoring
o f aquatic ecosystems and carcinogenesis studies.

5
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Scope o f Dissertation

Environmental carcinogenesis is responsible for the majority o f human and
animal cancers. Understanding the impact these environmental compounds have at the
cellular and molecular levels is imperative in determining the mechanistic pathways
involved in the early onset o f neoplastic development. Once these pathways have been
identified, they can ultimately be targeted for interference in efforts to eliminate or
control the process of carcinogenesis. This paper examines the individual and combined
effects o f two polycyclic arylamines, BZ and 2AF, on cellular proliferation and death,
and net cellular growth in the liver tissue of G. affinis.
G. affinis is not a traditional research organism. Therefore, in order to investigate
the effects ofPAAs on cellular proliferation and death, five potential biomarkers are
tested for compatibility with G. affinis. The first biomarker is an antibody to proliferating
cell nuclear antigen (PCNA). It is used for the detection of cellular proliferation. The
next three biomarkers are antibodies to p53 and cleaved caspase-3 and poly(ADP-ribose)
polymerase (PARP) proteins. These antibodies detect proteins associated with
programmed cell death. The last biomarker tested uses the terminal deoxynucleotidyl
transferase-mediated dUTP-biotin nick end labeling (TUNEL) method. TUNEL detects
DNA strand breaks associated with cell death.
Additionally, formation of foci, tumors and neoplasms are examined using
hemotoxylin and eosin (H&E) staining o f G. affinis liver tissue sections. HE staining,
along with the use of biomarkers for cell proliferation and cell death are examined to
reveal the extent of aberrant growths and overall changes in cellular proliferation, cell
death and net cellular growth in G. affinis livers after exposure to 2AF and BZ.

6
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CHAPTER II

LITERATURE REVIEW

Carcinogenesis

A Historical Overview

Cancer has plagued humans and animals for millions o f years and continues to do
so to this day. Neoplasms have been documented to occur as far back as the Mesozoic
era when dinosaurs ruled [1, 2], The bones of petrified, prehistoric, human remains, a
million and a half years old, have been found to have tumors [10]. Evidence o f squamous
papillomas, nasopharyngeal carcinomas and several suspected malignant melanomas
have been reported in Egyptian and Peruvian mummies dating back five to six thousand
years [38, 39]. An interesting note is that nasopharyngeal carcinomas are still prevalent
in the Egyptian population today [10]. Attempts to rid our selves o f the scourges of
cancer date back to ancient times.
Ancient Egyptian physicians were the first to recognize different type o f tumors.
They treated soft tumors by incision and drainage and hard tumors by excision. It was
“Galen the Pergamite”, (130-200 A.D.), who first categorized tumors, he considered
swellings, as 1) according to nature (swelling of breasts and uterus during pregnancy), 2)
exceeding nature (bone fracture calluses) and 3) contrary to nature (neoplasms). He also
characterized tumors as benign or malignant and was the first to recognize metastasis o f
tumors [10]. However, it wasn’t until the 1700’s that significant strides were made in
understanding the relationship of increased cancer incidences with that of environmental

7
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influences.
Beginning in 1713, with Ramazzini’s observations that the high incidence of
breast cancer in nuns may be attributable to their childless lifestyle, is when rudiments for
the groundwork on environmental influences in carcinogenesis was set forth. The late
1700’s continued on this path when J. Hill published, “Cautions against the immoderate
use o f snuff”, and P. Pott published, “Chirugical observations relative to the cancer of the
scrotum”. These publications documented the statistically significant relationship of
snuff to nasal polyps and chimney soot exposure to cancer of the scrotum. Further case
studies in the 18Q0’s continued to find associations with environmental agents, such as
arsenic, sunlight and aniline dyes, and increased cancer risk [40]. The advent of the
microscope and achromatic lenses in the early 1800’s brought about significant
advancements in understanding cancer, including diagnostic techniques.
Three pathologists, Johannes Mfiller, Rudolf Virchow and Karl von Rokitanski,
were able, with the use o f microscopic techniques, to establish the cellular basis of life
and more specifically the cellular basis o f cancer. Papanicolaou (1883-1962), a physician
and cytologist used cells shed from malignant neoplasms. He stained and observed them
on glass slides under the microscope and was able to morphologically define them as
cancerous. This method is routinely used today in screening tests for cancer: it is the
“Pap-smear” [2, 10, 41]. Evidence continued to accumulate in relating environmental
agents to cancer and these were especially evident in epidemiological studies.
Epidemiological research identified geographic, ethnic, lifestyle, occupational,
dietary, age, and gender differences, along with individual susceptibility, in occurrence of
tumors as well as tumor types. One of the earliest epidemiologic publications on lung

8
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cancer, by Doll and Hill (1950), hypothesized that increases in lung cancer were related
to atmospherically polluted areas and smoking of tobacco [42]. Additional studies by
Doll and Hill using 1465 lung cancer cases and 1465 controls supported their earlier
suspicions that smoking tobacco was a significant contributor to lung cancer. However,
they also emphasized that not all smokers would develop lung cancer, nor were all lung
cancers due to smoking indicating individual variation [43, 44). Another well known
epidemiological study in the 1960’s demonstrated that when people migrated from Japan
to the United States, their children did not exhibit the cancer patterns of their parent’s
homeland, but instead, they acquired the characteristic patterns of the new country
indicating geographic/cultural influence [45]. As epidemiologic studies identified
statistically significant environmental components in the etiology of cancer, molecular
techniques were developed that catapulted a revolution in the biological sciences
including environmental carcinogenesis.
The past 20 years has brought about the power to isolate, manipulate and
propagate genes and other genetic elements outside the host, then reintroduce them into
the same or different host. This has lead to extraordinary advancements in understanding
the complexities of carcinogenesis. These advancements include the use of restriction
enzymes, bacterial and viral cloning vectors, DNA ligases, DNA and RNA polymerases,
oligonucleotide probes, DNA, RNA and protein isolation and separation, immunoassays
and transfection just to name a few.
In the mid 1970’s, Sanger developed a technique for sequencing the nucleotide
sequence of genes and fragments of DNA [46]. This technique allowed investigators to
examine the differences in mutant and wildtype genes, especially those related to the

9
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onset of cancers. The 1993 Nobel Prize in Chemistry was presented to Kary Mullis for
his work in 1986 in developing the polyermase chain reaction (PCR). This technique
amplified segments ofDNA 106 to 109 times in a matter of hours, reducing the need for
week’s worth of cloning. Molecular techniques have also shed light on gene function.
For example, in 1975, Kohler and Milstein reported the production of antibodies o f a
predefined specificity [47]. The production o f antibodies has been essential in
immunoblotting and immunohistochemistry. This allows the investigator to identify the
expression o f particular genes in cells, such as those related to carcinogenesis. The
1980’s brought about the use of gene transfer experiments, wherein the genes of one
organism can be transferred and expressed into genome of another organism. This
transfer of genes gives insight into the function of particular genes, including oncogenes
and tumor suppressor genes, and possibly, the impact of carcinogens on the regulation of
homeostasis [2, 48-50].
With the ever-growing body of data and techniques now available to investigate
the etiology o f cancer, its complexities still elude us. While all cancers may fall into a
very broad definition, historical perspectives and current understandings have indicated a
disease process that does not fit into any comprehensive explanation. Debates over the
cellular origins of cancer, while fine-tuned, occur in scientific journals today [51-54].

Cellular Origins o f Cancer

It is common knowledge that cancers are composed o f cells that proliferate
outside the normal boundaries o f cell cycle control mechanisms. How this proliferative
capacity is brought about by viral infection, chemicals, radiation or inherited disorders

10
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has been o f great interest and study over the years. That cancers are cellular in origin
begs the question: From which cells does the cancer originate? Is it the mature tissue
cells dedifferentiating? Is it unregulated pluripotent stem cells? Different possible
cellular origins have been suggested such as: the embryonal theory of cancer,
dedifferentiation of mature cells capable o f dividing and the maturation arrest of stem cell
differentiation [53-58]. In a review of current literature on the topic, it appears that the
maturation arrest of stem cells is a likely candidate for the origin o f cancerous cells,
although dedifferentiation of mature cells may play a role outside of teratocarcinomas
[52, 53, 56, 58-62]. To understand the different possible cellular origins o f cancer, a
short review o f the different stages and progression of various cell types follows.

From Totipotent Stem Cells to Differentiated Tissue Cells

The journey from a totipotent stem cell to a terminally differentiated tissue cell is
well documented in developmental biology. Totipotent stem cells have the capacity to
become any cell type o f the organism [53, 63-66]. The fertilized egg, a zygote, is an
excellent example of a totipotent cell. In the correct environment, the zygote has the
potential to divide, differentiate and organize into a complex organism [67]. In all
vertebrates, these totipotent zygotes produce three populations of pluripotent stem cells,
the ectoderm, endoderm and mesoderm. These cells are described as pluripotent because
while they are stem cells and still have the capacity to differentiate into variety of cell
types, this differentiation potential is limited [68]. For example, the cells comprising the
ectoderm produce skin and nerve cells, but cannot produce the digestive and respiratory
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cells produced by cells o f the endoderm and vise versa [53]. These pluripotent stem cells
have lost totipotency and are now restricted in their differentiation potential.
Research with hematopoietic stem cells have shown that these pluripotent,
determined stem cells produce committed stem cells. These stem cells have further
restrictions on their potential for differentiation and are committed to produce only
predetermined cell types [52]. Once a cell is terminally differentiated, it no longer has
the ability to differentiate into another cell type. For example, a gramulocyte precursor
cell may terminally differentiate into a basophil or eosinophil [69]. These basophils and
eosinophils do not further differentiate nor can they revert back to a gramulocyte
precursor cell. These terminally differentiated cells are now fixed. Other terminally
differentiated cells, such as hepatocytes have the same restrictions in that they can only
produce more hepatocytes.
In summary, as totipotent stem cells produce pluripotent stem cells, and these
pluripotent stem cells produce more committed progeny cells, the potential for
differentiation becomes sequentially more restrictive. This continues until the progeny
cells become terminally differentiated. These sequential events of differentiation have
been extrapolated to models o f carcinogenesis due to the morphological and biochemical
similarities observed in cancerous cells in different tissues [52, 53, 58, 60, 70-72].

Embryonal Theory o f Cancer

The embryonal theory of cancer states that embryonal stem cells somehow
become isolated in tissue while still maintaining the potential to proliferate. Because the
stem cells are isolated in the developing organ, they are unable to differentiate with the
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surrounding cells. Then at some later time those isolated stem cells express their
potential for persistent growth. This proliferation occurs later in adult life and forms
tumors. That theory was widely accepted throughout the 19th century and was contrived
as early as 1829, when Recamier hypothesized that tumors originated from embryonal
cells that proliferated into adulthood [73].
While this embryonal theory of cancer has been laid to rest due to the fact that the
resting embryonic cells have never been observed, it isn’t that far off from the currently
held theories on the origin o f cancerous cells. One of these current theories is the
dedifferentiation o f terminally differentiated cells.

Dedifferentiation of Mature Cells in the Origin o f Cancer

Dedifferentiation is defined as the loss o f phenotype and the gain o f potential for
differentiation. While dedifferentiation occurs during development, it has also been
attributed to the cellular origin o f cancer. However, this has been debated because the
malignant cells in teratocarcinomas originate from undifferentiated germ cells and result
in an undifferentiated, not dedifferentiated, appearance in the tumor [74]. Thus some
have dismissed dedifferentiation in carcinogenesis and attribute its conception as a lack
o f understanding o f the normal molecular and cellular mechanisms involved in the
development and renewal o f tissue in organs, especially determined stem cells [53].
While this may be true for teratocarcinomas, it is argued that the majority of
cancers in any one tissue show a broad spectrum o f degrees of differentiation such as
basal cells to keratinocytes in squamous cell carcinomas and the biochemical properties
of mature differentiated hepatocytes in hepatocarcinomas [56]. Also, prostatic cancer
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cells are so well differentiated that it’s difficult to distinguish them from normal prostatic
acinar cells [75].

Maturation Arrest of Stem Cell Differentiation in the Origin of Cancer

Maturation arrest of stem cell differentiation is another currently held hypothesis
for the origin of cancerous cells in scientific literature. The first direct evidence for a
stem cell origin o f cancer was with the use of transplantable teratocarcinomas o f mice
[76]. In 1970, Roy Stevens injected teratocarcinomas from the genital ridge of FI mice
into the parental mice testes. These transplanted teratocarcinomas have since given rise
to teratocarcinomas from the normal genital ridge cells for over 200 generations in inbred
parental mice [58]. It is the morphological and developmental characteristics between
embryonic cells and cancer that has kept the stem cell origin o f cancer in the spotlight.
In 1994, Stewart Sell and G Barry Pierce published a paper reviewing the cellular
origin o f cancers for the following tissues: teratocarcinomas, epidermal/transitional cell
carcinomas, adenocarcinomas, hepatocellular carcinomas, pancreatic carcinomas, breast
cancers, prostate cancers and lung cancers. In each incidence they were able to identify a
determined stem cell that was required for tissue renewal in the carcinomas. The tumors
that resulted were not dedifferentiated. The contained many stem cells and imperfect
differentiation. In the late 1960’s these undifferentiated tumors were described as
caricatures of the normal process of tissue renewal [74].
It was once argued that malignant tumors were able to originate from benign
tumors. This was supported by erroneous assumptions that adenocarcinomas arose from
adenomatous polyps in the colon [77, 78]. However, it wasn’t understood at that time
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that adenomatous polyps are not benign tumors, but actually focal areas of hyperplasia
that have not progressed to cancer. Benign tumors have a narrow range of differentiated
cells, whereas a focal area of hyperplasia contains a wide range o f undifferentiated stems
cells along with their differentiated progeny cells [58]. It is the focal hyperplasias that
are the target for secondary or tertiary mutations due the numerous cycling cells that may
act as targets. This is seen in classical gastrointestinal carcinomas as well as
hematopoietic malignancies.
Both gastrointestinal and hematopoietic cells have a high turnover rates such that
early initiation events in differentiating cells would be gone before application of
promotional events several months later. However, if the initiation event takes place in
renewable stem cells, then the application o f a promoter months or years later would still
be able to induce a malignancy [79, 80], This is especially evident in hematopoietic stem
cell research where a great deal o f research has been conducted on the regulation of self
renewal since both the normal stem cells and cancer cells from this tissue are well
characterized and documented [52].
Several morphogenic and biochemical similarities have been observed between
stem cells and cancer cells. Pathways involved in the regulation of normal self-renewal
such as inhibition o f apoptosis by expression of bcl-2, and promotion o f self-renewal by
the Notch, Shh and Wnt signaling pathways have also been shown to be involved in
leukemias, colon carcinomas, epidermal tumors, medulloblastomas, basal cell carcinomas
and mammary tumors [52, 81-85]. An article in Science recently reported the discovery
of a gene product that is expressed in the early, multipotential state of embryonic stem
cells that virtually disappears at the beginning of differentiation. In efforts to elucidate its
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function, over-expression and gene silencing o f this protein in both embryonic stem cells
and human cancer cells resulted in hindered cell proliferation, suggesting a role in
regulation of proliferation [61].
Further evidence has accumulated in the tumor stem cell hypothesis including the
escape o f tumor cells from immune surveillance. G. Manzo has published a paper
suggesting the role of MHC-null/HSP70-very high phenotypes as a sort of ‘primordial
self tumor cell that cannot be recognized by either the MHC-restricted or the MHC-nonrestricted immunesurveillance systems, thus eluding detection and allowing for
proliferation as with undifferentiated embryonal cells [57].
As research progresses and evidence continues to mount, the stem cell hypothesis
for the origin o f cancer cells has held steady, but not without dissenters. They argue that
in hepatocarcinogenesis, the precursor lesions are clearly the mature hepatocytes [56].
This was observed in preneoplastic foci o f rat livers 11 days after initiation with
diethylnitrosamine and promotion with 2-acetylaminofluorene in the three separate
experiments [86]. Therefore, both dedifferentiation and stem cell arrest theories have
neither been proved nor disproved. Moreover, they appear to demonstrate the variance
observed in different neoplasm classes.

Stages o f Carcinogenesis

Carcinogenesis is the multistep progression o f cells sequentially undergoing a
selective growth advantage, clonal expansion, and neoplastic formation. This multistep
progression can be categorized into two main themes, the stages of neoplastic formation
and the components contributing to the process [2]. The three major stages o f neoplastic
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development are often described as initiation, promotion, and progression Several other
substages occur during each major stage [87]. Although there is no uniform definition
for initiation, promotion, or progression due to their links with individual experimental
procedures and interpretations, they can be generally defined by their molecular, cellular,
and tissue level characteristics [2].

Initiation

Initiation is generally referred to as the earliest stage of cancer where DNA
damage has occurred in a cancer related gene. This damage may originate from
spontaneous mutations, UV radiation, chemical mutagens, hypomethylation, inherited
mutations, DNA adduct formation, replication errors and a host of other factors [12,41,
88-93], Initiation typically is associated with a rare change in cellular phenotype [56],
This new phenotype is a critical component to initiation. It gives the rare cell a selective
growth advantage and an altered response to its environment when compared to the
neighboring normal cells [41, 45]. In a study of hepatocarcinogenesis, four major factors
were identified in initiation: a) DNA interaction, b) dependence on a round o f cellular
proliferation, c) cells with resistance to some of the inhibitory effects o f the carcinogen,
and d) selection of new resistant cells [94, 95]. In a minireview o f environmental
carcinogenesis and biotechnology, initiation is described as damages to DNA associated
with the early changes in cancer development such as base pair mutations [2]. Initiators,
with rare exceptions, usually act as both initiators and promoters in the progression of
neoplasms.
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Promotion

Although the general characteristics o f initiation are virtually identical to
promotion, promotion is considered a subsequent step to initiation [96]. The promotion
stage is thought to last much longer than the initiation stage. Promotion is carried out by
proliferation and expansion o f the rare initiated cell to form focal proliferations that
appear similar to benign neoplasms [97]. These focal proliferations either redifferentiate
to normal appearing tissue or slowly develop into cancer [98]. During promotion,
initiated cells survive to a greater extent than non-initiated cells and the odds o f
additional genetic damage accumulating in the expanding and proliferating population of
initiated cells is enhanced [41]. While the mechanism o f clonal expansion is not evident
in most systems, differential inhibition has been identified as a dominant mechanistic
pattern in the liver of rats [45].
To differentiate initiation from promotion a mathematical model has been
postulated where an initiator is any agent that increases the transition of a normal cell to a
once-hit intermediate cell and that a promoter is any agent that acts on these intermediate
cells to increase their proliferation or decrease the rate o f differentiation or death giving
rise to intermediate lesions [72]. It is these intermediate cells, not normal cells, which
may on rare occurrence progress to malignant cells.

Progression

Progression, the last stage of neoplastic development, is self-promoting and can
be interfered with by diet, drugs, or xenobiotics. It is characterized by increased changes
to chromosomes/karyotypes and the progressive nature of the cell to elude normal growth
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and differentiation controls [2]. It has been demonstrated in hepatocytes, that
preneoplastic nodules are phenotypically homogenous in a given tissue even with the use
of different initiators and promoting environments, however, the resulting cancers are
quite diverse and heterogeneous [97]. While the acquisition o f heterogeneity and
diversity has not been worked out yet, it appears to be acquired with the malignant state.
Agents that promote the transition of a cell from a promotion to a progression
have the characteristic of inducing chromosomal aberrations [99]. The mechanisms
involved in karyotypic instability are numerous. Contributing mechanisms may be
altered telomere function, gene amplification, topoisomerase function, DNA
hypomethylation, mismatch repair genes, oncogene and tumor suppressor gene function,
spontaneous instability and sister chromatid exchanges [19,45, 93, 100-105], One or
more these mechanisms are exhibited in neoplasms and are highly likely to be involved in
the progression o f carcinogenesis [99].

Contributing Factors to the Genesis o f Cancer

As research continues to clarify our basic understanding of the development of
cancer, the factors contributing to the process have grown. While numerous contributing
factors have been identified, they are classified into two major groups, heritable and
environmental factors. These major classes may act individually or in combination with
one another. The heritable forms of cancers are either indirect contributors or direct
contributors. The indirect heritable forms are more common and are associated with
predispositions to certain cancers depending on additional factors such as environmental

19

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

factors, whereas direct heritable forms of cancer act independently and are rare by
comparison.
Directly heritable cancers include familial polyposis coli, Gardner’s syndrome,
Paget’s disease, and retinoblastoma to name a few from a short list. All of these heritable
cancers are inherited as autosomal dominant genes [106]. As the environment comes into
play in the development of cancer, the list grows exponentially regarding indirect
heritable predispositions to certain cancers. Numerous genes have been implicated in the
development o f cancers. These genes range from oncogenes and tumor suppressor genes
to metabolically active genes [41].

Oncogenes

Oncogenes originate from proto-oncogenes and certain viruses. Proto-oncogenes
are genes involved in the normal growth and differentiation processes. However, when
genetic changes occur to proto-oncogenes, such as an assault by a chemical carcinogen,
they can be activated to oncogenes [107, 108]. Additionally, viral sources can integrate
oncogenes into the genome o f a host cell [10, 48], An example is the human papilloma
virus (HPV) that is associated with the majority of uterine and cervical cancers [109].
Oncogenes perform various functions such as growth factors, protein kinases and
nuclear transcription factors. Growth factors act as signals for the stimulation of normal
growth and development. However, when regulatory mechanisms or the structural
architecture of these signals is disrupted, these same growth factors can cause
uncontrolled growth o f the effected cells [110]. In addition to the influence of growth
factors on cellular growth and differentiation, protein kinases also play a significant role.
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Disruptions in the normal functioning of protein kinases are evident in human
tumors [111]. For examples, the ras family of genes, act as protein kinases and they
specifically code for guanosine triphosphatases. These protein kinases function in
association with membrane-associated G proteins in signal transduction pathways for
normal growth and differentiation[l 12]. During normal functioning, ras gene products
participate in the phosphorylation o f GDP to GTP upon signaling from an external
mitogenic signal. When the ras gene is mutated, GTP cannot be hydrolyzed to GDP
[113]. The result is a continuous mitogenic signal and accounts for large number of
human tumors [111], Ultimately, the signaling cascade for normal growth and
differentiation leads to highly regulated gene expression through transcriptional
regulation.
Transcriptional regulation is mediated by downstream transcription factors.
Transcription factors have two functional domains, one that binds DNA and another for
protein-protein interactions. These binding domains are critical to transcription, since
RNA polymerase II cannot directly bind DNA promoter sites and requires interaction
with transcription factors to bind DNA and initiate transcription [114]. An example is the
well studied nuclear transcription factor, c-myc. It has been shown to regulate cell
proliferation, differentiation and transformation. Mitogenic stimuli such as chemical
carcinogens can induce c-myc expression in quiescent cells and those cells can enter the
cell cycle [115], Genetic aberrations and expression amplifications o f c-myc have been
associated with bladder cancer, breast cancer, ovarian cancer and non-small cell lung
cancer [116-119].
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In summary, oncogenes, resulting from inappropriately activated proto-oncogenes
augment the potential of neoplastic formation [41], Chemical carcinogens can induce
inappropriate activation of proto-oncogenes [120], This includes base pair substitutions
and frameshift mutations that arise from DNA adduct formation after exposure to
chemical carcinogens such as polycyclic arylamines [121,122]

Tumor Suppressor Genes

Contrasting oncogenes are tumor suppressor genes that when inappropriately
inhibited are also involved in neoplastic formation [41], Tumor suppressor genes are
multi-functional and their expression is required for negative regulation of cell growth. If
both copies of the gene are absent or inactive, uncontrolled cellular proliferation will
result [123], Examples o f tumor suppressor genes are p53, RB-1, BRCA1, BRCA2, NF1
and hMLHl [124],
The p53 protein, for example, is usually found in low concentrations in the cell
and can be activated by DNA strand breaks for cell cycle arrest and/or apoptosis [125],
Mutations in the p53 tumor suppressor gene appear in approximately 50-55% of all
human cancers [126], Environmental carcinogens are involved in these mutational events
and can lead to the inhibition ofp53’s tumor suppression functions either by inactivation
of p53 or point mutations [127]
As evidenced, both proto-oncogenes and tumor suppressor genes are critical for
the normal growth, development and division of cells. However, alterations to these
genes, their expression and/or function play a significant role in neoplastic formations
[45, 128-131]. In addition to genetic predispositions to cancer, environmental
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carcinogens also act as highly significant predictors of increased cancer incidence
through their interaction with proto-oncogenes and tumor suppressor genes.

Environmental Contributors and Biotransformation

It has been unequivocally determined that numerous components of the
environment contribute the onset of cancers. These include x-rays, irradiation, infections,
pollution, diet, tobacco, combustion products, occupation, chemicals, and reproduction
just to name a few [2, 88, 89,132,133]. These environmental components act either
directly or indirectly in altering the normal functioning of cellular growth and division
[44, 101, 134]. For example, tobacco smoke contains polycyclic aromatic hydrocarbons
(PAH) that form DNA adducts. In a study, samples from 40 heavy smokers who recently
quit were assayed for PAH-DNA and 4-aminobiphenyl-hemoglobin adducts. A
significant reduction in adduct formation was observed in those ex-smokers negative for
cotinine, a component of tobacco smoke indicating that tobacco smoke was responsible
for adduct formation [135]. Even the sun’s ultraviolet rays have been shown to induce a
variety of skin cancers [136].
Acting in concert with environmental agents are biologically active proteins that
function in the biotransformation o f xenobiotics and metabolism o f endogenous
chemicals [24,137, 138]. Several chemicals identified as carcinogens are metabolically
activated to their carcinogenic state and are referred to as promutagens and
procarcinogens [139, 140]. The metabolism o f xenobiotics in the liver is largely due to
the cytochrome P450 family o f biotransformation enzymes [141, 142].
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Cytochrome P450 is the most catalytically versatile enzyme and functions in
detoxifying or activating a large number of environmental compounds to reactive
intermediates [143], The standard reaction catalyzed by cytochrome P450 is
monooxygenation, the transfer of one oxygen atom to a substrate and the other to water
via NADPH [24], Different compounds can interact with different cytochrome P450s
acting as either substrates for biotransformation, P450 inhibitors or P450 inducers [24],
Polymorphisms, heritable or chemically induced, in the alleles o f these metabolically
active enzymes can alter their function and result in increased susceptibility to neoplastic
formation upon exposure to environmental carcinogens [144, 145], There are more than
15 different forms of P450 enzymes in human liver microsomes such as CYP1A1/2,
CYP2A6, BYP2B6, CYP2C8/9/18/19, CYP2D6, CYP2E1 and CYP3A3/4/5/7 [146,
147], Subjects with two active CYP2D6 alleles, rapid metabolizers, are at an increased
risk o f developing hepatocellular carcinomas [148], The interaction between
environmental carcinogens and metabolic variation has fueled increased efforts to
measure biomarkers in exposure studies.

Progress and Prevention

The pathogenesis of cancer is more often than not, associated with environmental
factors [6,13, 89,132,149,150], Higginson addresses two major control strategies for
cancer. The first being increased regulation limiting or prohibiting as little as minute
quantities o f pollutants into the surrounding environment. While this has reduced some
incidences of cancers, due to regulatory and legislative hurdles, along with resistance to
lifestyle changes this is not likely to result in a substantial decrease in future mortality
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rates associated with cancer [13]. The second control strategy is long term research into
the cellular biological mechanisms underlying carcinogenesis and interfering with those
mechanisms. Although long term, the second control strategy is much more likely to
have a substantial impact on future mortality rates associated with cancer.
While much of risk assessment and management 20 years ago was attributed to
mathematical extrapolation, a substantial increase in our understanding of molecular
mechanisms has been driven by new biotechnologies [41]. For example, DNA adducts
can now be detected by gas chromatography coupled to mass spectrometry at levels as
low as 10 finol/g. This allows for the direct measurement of a specific chemical and/or
its metabolite’s interaction with DNA. It can also indicate exposure of individuals to
specific carcinogens when adducts are detected in tissue samples [4]. Once a chemical
has been identified to interact with DNA, protein and DNA sequencing along with
utilization o f biomarkers can determine what effects at the molecular level are occurring
due to this interaction, this is especially relevant in environmental carcinogenesis studies.
Treatment in the prevention o f cancer mortality rates has increased as our
knowledge of the etiological processes involved has grown. Typically, the more that is
known about a particular cancer, the better the rate o f success in its treatment [2]. The
current hypothesis into tissue-specific stem cells and neoplastic development has the
potential to change the manner in which we approach cancer therapy. Existing therapies
target the greater mass o f tumor cells. However, normal stem cells from various tissues
are more resistant to these chemotherapies than their mature cells from the same tissue
[52]. The use of human stem cells for cancer therapy has opened possibilities for
vaccination approaches in several solid tumors and hematologic malignancies [151].
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The Cell Cycle

In order for cells to maintain a homeostatic environment in complex organisms,
an equilibrium is achieved in tissues where some cells are dividing, some are growing,
some are differentiating, some are quiescent and others are dying [152]. This equilibrium
is essential for the normal development and maintenance of tissue. Cells are able to
sustain this homeostatic environment through a process referred to as the cell cycle. The
cell cycle is a highly regulated process that is dependent on an orderly sequence of
signals received from its internal and surrounding environment [153]. Ceils that are not
in the process o f growth and replication are said to be in the quiescent GO-phase. In
replicating cells, there are 4 major phases involved in the cell cycle; G1-, S-, G2- and bi
phase. A schematic of the cell cycle is illustrated in Figure 1 [154].
During G1-phase, DNA uncoils from its condensed state and RNA and protein
synthesis occur in preparation for DNA synthesis. DNA is synthesized in the S-phase for
replication of the genome in preparation for cell division. The G2-phase prepares the cell
for division by condensing the DNA, and further RNA and protein synthesis occurs. The
M-phase is when the cell undergoes active cytoplasmic and nuclear division either
through mitosis or meiosis. Checkpoints occur before the transition from one phase of
the cell cycle onto the next [154-156].
There are 3 checkpoints that ensure the proper completion of one phase of the cell
cycle before progression to the next. During normal cellular cycling, the Gl/S
checkpoint acts in G1 and assures the cell is competent (i.e. DNA is not damaged) for
entry into the S-phase. The G2/M checkpoint oversees the completion of S-phase and
passage into M-phase. The M checkpoint regulates spindle formation and exit from M-
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phase [157]. There are also well-established divergences from this cycling, for example
when DNA damage occurs due to environmental assaults such as exposure to chemicals,
UV light, viruses, etc. When DNA damage occurs in the cell, a cascade of regulatory
proteins such as RB, p53, cyclins C, D and E and cytokines function to keep the cell in
G1-phase until the damage has been corrected before allowing entry to the S-phase [12,
101,152, 158-160], This allows the cell to maintain its genomic integrity by repairing
DNA damage before it is passed on to daughter cells.
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Schematic of the Cell Cycle.

In circumstances where the DNA damage is too extensive for the cellular DNA
repair machinery, the cell will undergo an internally programmed cell death [161].

This

pathway to cellular death is called apoptosis and is also highly regulated through a
cascade of signaling events [162-164]. The pathway from the cell cycle to apoptosis was
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proposed as: p53 —*■WAF1/CIP1 —> Cyclin E/CDK4 —»■Gl/S arrest —►apoptosis [158,
165-167],
Once the cell is committed to apoptosis another sequential cascade o f signaling
events occur. These signals involve the family o f caspases and poly(ADP-ribose)
polymerase, among a number of other signaling molecules that lead to cellular
condensation and the eventual fragmentation o f the cell’s genome. The specific cell
cycle control and apoptotic components addressed in this paper are the proliferating
cellular nuclear antigen (PCNA), (PARP), caspase-3 and p53 tumor suppressor protein. .

Proliferating Cell Nuclear Antigen

PCNA is a highly conserved protein, present in higher plants, yeast and mammals,
that was originally isolated from patients with systemic lupus erythematosus [168,169].
It is typically a 36 kDa cyclin that functions with DNA polymerases 8 and s and is
involved in DNA replication and repair, transcription and cell cycle control [170-176].
PCNA appears in the nucleus in late G1-phase, increases during the S-phase, and
decreases in G2- and M-phases [177,178]. Its synthesis directly correlates with cellular
proliferation [175, 179]. Several studies have demonstrated that normal non-cycling cells
and tissues synthesize very little or no PCNA, while normal cycling cultured cells
(limited life span) synthesize PCNA during their low number passages, and in
transformed cells (immortal) PCNA synthesis is significantly elevated in varying
amounts [180]. PCNA has been observed as a prominent component o f many cancers
including ovarian, gastric, oral, pharyngeal, bladder, hepatic and leukemia among others
and tumor cell lines [181-186]. Upon mitogen-induced blast transformation, peripheral
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blood lymphocytes tested positive for PCNA, whereas normal peripheral blood
lymphocytes did not exhibit detectable amounts, indicative ofPCNA’s involvement in
DNA replication [187]. PCNA has been shown to interact with several other biologically
active constituents, such as p21, cyclins, MyDl 18, Gadd45, mismatch repair proteins,
human DNA ligase and Fenl [172, 188-191].
Owing to PCNA’s presence in replicating cells, it has been utilized as a biomarker
for cellular proliferation. This has led to numerous studies investigating the expression of
PCNA, especially in neoplasms for prognostic significance. For example, a positive
correlation was observed between the malignancy index and PCNA index (PI) in glottic
squamous cell carcinomas [192]. Significant correlations were found between PI and
grade, cervical metastasis, lymphovascular invasion, tumor margins, local-regional
recurrence and survival in laryngeal cancer patients [193]. In another study, a higher
percentage o f intense PCNA staining was observed in laryngeal carcinomas that
progressed into invasive cancers [194], These results indicate the possible utility ofPI in
treating and assessing prognosis in laryngeal carcinomas. In breast cancers, PCNA
scores were associated with ‘shorter’ disease-free and overall survival times than tumors
with low PCNA scores [195]. A strong correlation was also found to exist between the
PI and prognosis in squamous cell carcinoma o f the cervix [196]. In addition to human
cancer studies, PCNA has also been used as a biomarker in aquatic species for
proliferation and carcinogenesis studies.
Teleost fish undergo continual growth and their eyes expand in concert with this
growth. In studies with these fish, PCNA was used to determine the spatial distribution
of cellular proliferation in these teleost retinas [174, 197]. Immunochemical localization
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of PCNA in mussel digestive gland tissue revealed its capacity to proliferate in all cell
types, opposing the suggested existence of one stem cell in the epithelium [198]. PCNA
was also used in an investigation into the regulation of cell death and proliferation of
chemically induced neoplasias in Fundulus grandis after exposure to 6.7 pM N-methylN’-nitro-N-nitrosoguanidine and 6.9 mM 2-aminofluorene. The authors noted the use of
PCNA as a biomarker significantly augmented the assessment o f these chemicals on liver
cells [199]. PCNA’s preferential expression in dividing cells makes it a useful molecular
tool in the studies o f cellular proliferation. And, when used in conjunction with other
biomarkers, can be used to determine the ratio of cellular proliferation to cell death.

p53 Tumor Suppressor Gene

The p53 tumor suppressor protein is one of the most highly characterized cancer
related proteins. Its major functions are in maintaining genomic integrity by pausing the
cell cycle to allow for DNA damage repair before replication, or with extensive DNA
damage, inducing programmed cell death (apoptosis) to prohibit passing on of damaged
DNA to daughter cells [161], This is accomplished by the accumulation ofbiologically
active p53 upon DNA damage and is highly regulated [159]. p53’s expression is also
associated with increased levels in transformed and tumor cell lines [200]. Mutations in
the p53 gene are one o f the major genetic aberrations associated with human cancers
[93]. Therefore the status of p53 expression, along with other indicators, is useful in
investigating cell cycle disruption including apoptosis [201, 202].
A major role o f the p53 gene is its ability to induce the transcription of genes that
contain a p53 response element. The p53 protein’s DNA-binding domain is located in
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the central region (amino acids 90-290) and its protein-binding domain is in the aminoterminal end (amino acids 1-42), while the carboxy-terminal negatively regulates its
DNA-binding activity [203-208], The DNA sequence o f p53 has been characterized in
over 20 different species and while the genes are highly conserved, their homology is not
uniformly distributed. Five blocks were identified as highly conserved, and four o f those
five blocks are located in the central DNA-binding region and the other is located in the
amino-terminal protein-binding region [209], These conserved regions are indicative of
the critical importance of p53’s DNA-binding function and mutations in this central
region have been implicated in neoplastic development [93, 126,210-216],
The tumor suppressor function of p53 is accomplished by its regulation of the cell
cycle in response to DNA damage. The absence o f p53 does not inhibit mitotic or
meiotic cell cycles, but it does significantly correlate with high incidences of tumor
formation in p53-null mice [217], In UV-irradiated normal human skin cells, p53 protein
levels are significantly increased [218], This presence ofhigh p53 protein levels during
DNA damage correlates with the time involved in repairing the DNA damage [219],
Repression of the cell cycle by p53 in response to DNA damage is suggested to occur
through transcriptional suppression and transcriptional activation of specific target genes
[220], For example, the p53 protein inhibits the expression of PCNA and c-fos whose
products are required for cell proliferation and cell cycle progression [221, 222], When
extensive DNA damage occurs, such as that with radiation, normal mice thymocytes
undergo apoptosis, however, mice that lack functional p53 develop cancer and are
resistant to radiation-induced programmed cell death [223],
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Further evidence of the tumor suppressor role of p53 was examined in hypoxiainduced apoptosis. Hypoxia exposed p53-expressing mouse embryonic fibroblasts
(MEFs) accumulate wild-type p53 and undergo significantly increased apoptosis while
their p53~ null counterparts were resistant to hypoxia-induced apoptosis [224].
Additional studies also revealed an association with p53 and apoptosis. In a study of
apoptosis in cardiac myocytes, chronic rapid ventricular pacing for 3 weeks induced
congestive heart failure, increased levels of p53 and apoptosis, whereas control cells did
not [225], MN/CAIX (MN) is a carbonic anhydrase that has a strong association with
cervical, bladder, oesophagus, and colon cancers [226, 227]. In Ma Tu cells, an MN
promoter was repressed by wildtype p53, but stimulated by (143Val~*Ala) mutant p53 in a
dose-dependent manner [227]. This is indicative of p53’s tumor suppressor function and
the opposing effect mutations can induce in the p53 protein.
More than 5000 mutations have been described in the p53 gene and it is estimated
that -50% o f all Jiuman cancers contain mutated p53 genes [126, 228], These mutations
are typically point mutations and can have a profound effect on the resulting mutant p53
protein. The overwhelming majority of p53 mutations detected in human cancers are
localized in the central region o f the gene in exons 5-8 [229], The occurrence o f p53
mutations in exon 5 of occupational bladder tumors was around 70%, with C to T
transitions being the most common mutation while codons 151 and 152 acted as ‘hot
spots’ [212]. In oesophageal carcinomas, 38% had p53 gene mutations in exons 5-9)
[213]. This suggests that exposure to environmental carcinogens may be the predominant
etiological factor in oesophageal cancers. Thyroid neoplasms vary from slow growing
differentiated adenocarcinomas to rapid proliferation of undifferentiated carcinomas.
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When investigating the p53 mutations in carcinomas of the thyroid gland, 6 of 7
undifferentiated carcinomas had base pair substitution mutations in exons 5-8, while no
mutations were detected in differentiated papillary adenocarcinomas [230]. Thus, in
addition to the use o f biomarkers for wildtype p53 levels in apoptotic studies, mutations
in p53 can also be used as biomarkers in carcinogenesis studies.

Caspase-3

Caspase-3 is a member of a family o f intracellular aspartate-specific cystein
proteases, called caspases. Caspases play a significant role in apoptosis through a
downstream cascade o f activation and self-activation [231 -234]. This cascade ultimately
results in cytoskeletal changes, chromatin condensation and DNA fragmentation [162,
235], Caspases are divided into 2 subclasses, the initiators (apoptosis signaling events)
and the executioners (cellular dismantling). The initiator caspases (i.e. caspases-8 and 9) activate the executioner caspases (i.e. caspases-3 and -7) [235, 236]. Caspase-3 is one
of the major proteases responsible for the cleavage of PARP in programmed cell death.
Activation of caspase-3 from its proform, called apopain, to its active form, named
CPP32, is essential to its function as an initiator signal for apoptosis [237,238].
Activation of caspase-3, to CPP32, is mediated by a number o f upstream
proteases: caspase-6, -8, -9 and-10, interleukin-ip converting enzyme (ICE), granzyme
B and synthetic peptides containing the arginine-glycine-aspartate (RGD) motif [237,
239-241]. These proteolytic proteins activate caspase-3 by cleaving the foil length
proform, at critical Asp residues in the interdomain linker loop, into large and small
subunits, p i7 and p i2. These two subunits are closely associated in forming two
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heterodimers that form a tetramer, resulting in the enzymatically active form o f CPP32
[242-244]. Once activated, caspase-3/CPP32 is involved in the cleavage of several
substrates involved in DNA repair, pre-mRNA splicing, sterol biosynthesis, sustaining
Rho-GTPases, DNA fragmentation, and pyrimidine nucleotide synthesis [244, 245].
The cleavage products o f these substrates are all associated with processes
involved in programmed cell death. Several studies using caspase-3 inhibitors (Z-VADfmlc, Z-DEVD-fmk or Ac-DEVD-CHO) allow for the examination of caspase-3 activity
[245-247,248: Park, 1998 #840, 249]. These studies have helped elucidate some of the
functional characteristics o f caspase-3. In the early stages o f apoptosis in SK-HEP-1
hepatoma cells induced by ginsenoside Rh2 or staurosporine, caspase-3 activity increased
and cleaved p21, an inhibitor of cyclin kinases, in a dose-dependent manner [250].
Caspase-3 protease is implicated in genistein-induced apoptosis of prostatic carcinomas
cell lines. Genistein was shown to activate caspase-3 and inhibit growth and proliferation
of prostatic carcinoma cell lines via apoptosis. When caspase-3 activation was inhibited
so was genistein-induced apoptosis [247]. Activation ofDFF-45/ICAD, a subunit of the
DNA fragmentation factor (DFF), mediates genomic DNA fragmentation during
apoptosis. Tang and Kidd reported that DFF-45/TCAD has two cleavage sites for
activation and that caspase-3 is required for cleavage o f its carboxyl-terminal caspase
cleavage site [235]. Caspase-3 deficient mice gave the first strong evidence for a major
role in neuronal apoptosis by caspase-3 [251]. Additionally, caspase-3 is also
hypothesized to be involved in c-Myc-induced apoptosis [252]. Recent studies have
identified another caspase-3 substrate, hPMCA4b. hPMCA4b is a subunit of plasma
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membrane Ca2+ pump (PMCA) that maintains low intracellular Ca2+ levels. Changes in
intracellular Ca2+ homeostasis are associated with apoptosis [253].
Another critical role in caspase-3 activation is its downstream cleavage of
poly(ADP-ribose) polymerase (PARP), which also leads to DNA fragmentation.
Caspase-3 cleavage of PARP and the resulting DNA fragmentation is a hallmark of
apoptosis. Caspase-3 activation of PARP is specific to programmed cell death, whereas,
during necrotic cell death an additional cleavage is involved [254]. These studies
underscore the advantage o f using cleaved and full-length caspase-3 biomarkers in
investigations of cellular apoptotic events.

Poly(ADP-Ribose) Polymerase

Poly(ADP-ribose) polymerase is a 113-116 kDa protein involved in DNA
replication, DNA repair, genomic stability, cellular differentiation, cell death (both
apoptotic and necrotic) and chromatin functions depending on whether it is in its full
length or cleaved form [255-257]. PARP is divided into three major functional domains:
1) a DNA-binding domain in the N-terminus, 2) automodification sites in the central
fragment, and 3) catalytic and nucleotide-binding domains in the c-terminus. The DNAbinding domain exhibits two zinc fingers and two helix-tum-helix motifs that recognize
altered DNA structures and bind to them. It also contains a DEVD sequence that is
cleaved by caspases (i.e. caspase-3) during apoptotic cell death resulting in 89- and 24kDa fragments. The automodification domain has 15 glutamate residues that may act as
potential ADP-ribose polymer acceptors. This catalytic domain is involved in
nicotinamide adenine dinucleotide (NAD) catabolism. The ADP-ribose moiety ofNAD
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is utilized in the formation o f chains o f poly-ADP-ribose onto acceptor proteins, resulting
in the acceptor protein’s inactivation [257, 258].
PARP itself is the main target protein of poly(ADP-ribosyl)ation both in vitro and
in vivo [259]. When DNA damage resulting in DNA strand breaks occur, PARP binds to

DNA at the site of the DNA strand break and concomitantly synthesizes oligo- or
poly(ADP-ribose) (PAR) chains that covalently bind itself (or various acceptor proteins).
Binding o f PARP to DNA strand breaks is suggested to function in the suppression of
chromosomal recombination. This is observed in PARP-1 knockout cells, where
spontaneous and DNA damage-induced sister chromatid exchanges occur at high
frequencies [260]. When PAR binds PARP at PARP’s NAD binding-domain it results in
a negative charge that causes PARP to dissociate from the DNA strand breaks. This
catalytic activity o f PARP is dependent on DNA strand breaks and NAD, and is
modulated by automodification [257],
In addition to DNA repair, numerous studies have implicated PARP in the
apoptotic process [238, 255,261-265]. Investigators have shown that caspase-3 cleavage
ofPARP occurs at the onset o f apoptosis and separates the two DNA-binding zinc fingers
from the automodification domain thus precluding the catalytic domain ofPARP from
being recruited to DNA strand breaks [238], It was also demonstrated that during the
early stages ofFas-mediated apoptosis osteosarcoma cells, HL-60 cells, 3T3-L1 cells and
PARP+/+ fibroblasts all underwent a transient burst of poly(ADP-ribosyl)ation 4 days
after exposure to anti-Fas and cyclohexamide for apoptosis induction. This transient burst
did not occur with PARP-depleted 3T3-L1 antisense cells or PARP -/- fibroblasts.
Following the transient burst, poly(ADP-ribosyl)ation declined significantly, and at the
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same time, caspase-3 cleaved PARP, DNA was cleaved and PAR moieties bound to
proteins were degraded [255].
Further investigation into the transient burst of poly(ADP-ribosyl)ation prior to
caspase-3 cleavage ofPARP suggests it may be implicated in histone HI correlation with
intemucleosomal DNA fragmentation. PARP inhibitors have demonstrated an inhibitory
effect on the generation of DNA fragmentation during apoptosis. It is hypothesized that a
change in polarity of the basic portions of histone HI by PAR reduces its affinity for the
intemucleosomal DNA region, thus relaxing the solenoid structure o f chromatin resulting
in an increased susceptibility o f chromatin to cellular endonucleases [265]. This is
further supported by the restoration of the chromatin solenoid structure through the
degradation o f PAR units by poly(ADP-ribose) glycohydrolase on histone HI [266].
In addition to caspase-3 cleavage ofPARP, granzyme B and perforin have also
been shown to cleave PARP. However, granzyme B and perforin’s cleavage ofPARP, in
a cell free extract of purified bovine PARP, produces four fragments, 64, 61, 54 and 42
kDa, that differs from the major 89 kDa fragment produced by caspase-3 cleavage. The
64 and 54 kDa fragments contained the amino-terminal and carboxy-terminal end,
respectively, o f which only the 54 kDa fragment was active since it contained the
catalytic domain. Secondary cleavage o f the 64 and 54 kDa fragments produced 61 and
42 kDa fragments, respectively. Of these fragment, the 42 kDa fragment was also shown
to be active. When Jurkat cells were incubated with granzyme B and perforin both 89
and 64 kDa PARP fragments were observed at different time points [267]. While this
demonstrates the different enzymes capable o f cleaving PARP, it also indicates the
variable cleavage patterns ofPARP that may be detected.

37

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Different fragmentation patterns of DNA by PARP have also been documented
during necrotic and apoptotic cell death in HL-60 cells. Using etoposide to induce
apoptosis and cytochalasin B to induce necrosis, agarose gel electrophoresis of DNA
revealed significant DNA degradation in the apoptic cells and only a slight increase over
the controls in necrotic cells. Cleavage ofPARP itself also differed between apoptotic
and necrotic cells. Control cells revealed a major band at 113 kDa and a minor band at
89 kDa and developed another minor band of 55 kDa after 24 hrs. The apoptotic cells
began with a minor 113 kDa band and major 89 kDa band at 3 hrs and by 10 hrs the 113
kDa band had disappeared and the 89 kDa band stayed strong for the full 48 hrs. The
necrotic cells maintained a strong 113 kDa band and an 89 kDa band that produced more
fragments (50, 40 and 35 kDa) after 24 hrs. This stable presence of additional fragments
ofPARP from necrotic cells suggests that this is not a random degradation. Additionally,
this could be utilized as an assay to differentiate apoptotic and necrotic cell death [254].
Biomarkers for the detection ofPARP in both its full-length and cleaved forms are useful
in environmental carcinogen studies. A decrease in the full-length form ofPARP with a
concomitant increase in its cleaved form is indicative of cell death.

Detection o f DNA Fragmentation During Cell Death

In maintaining genomic integrity, cells are amazingly resilient. They have several
mechanisms that give them the ability to repair moderate amounts of DNA damage and
when DNA damage is too extensive for repair, programmed cell death ensues. This
ensures that aberrant DNA is not passed on to daughter cells, thus maintaining the
genomic integrity of future cell populations [268, 269]. An aspect of cell cycle disruption
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that occurs with exposure to toxic chemicals is whether or not the chemical directly
causes injury to the cell resulting in necrotic cell death, or whether the chemical affects
the genetic machinery inducing an apoptic cell death [202].
Morphological and biochemical distinctions differentiate necrotic and apoptic cell
death [270-272], In contrast to necrotic cells, apoptic cells exhibit cellular shrinkage,
DNA fragmentation, plasma membrane blebbing, protein production and condensation of
the cytoplasm [164, 273], Necrotic cells have cellular swelling, a loss of cell membrane
integrity, and a release o f lysosomal enzymes. Recently, evidence has been presented
that programmed cell death occurs in pathways other than apoptosis. Another pathway is
autophagic-programmed cell death (PCD) and it is a biochemically and morphologically
distinct pathway from apoptotis [273]. These forms of PCD serve a protective function
by removing damaged or initiated cells, thus ensuring they do not proliferate [274].
Interference with these protective functions by toxic chemicals may enhance or prohibit
PCD [161,275].
The most highly characterized type of programmed cell death is apoptotic cell
death. Morphological characteristics of apoptosis are condensation and fragmentation of
the cell and o f nuclear chromatin, along with phagocytosis by neighboring cells [161,
164,274, 276]. The fragmentation o f chromatin by endonoucleases during apoptosis
produces a signature DNA ladder, ranging from about 50-300 base pair multiples
depending on the cell type [277]. To compare and contrast this pattern of DNA
fragmentation in apoptotic and non-apoptotic cells, DNA from separate nuclear and
cytoplasmic extracts were examined. Agarose gel electrophoresis o f isolated DNA from
the fractions o f apoptotic cells resulted in two classes o f oligonucleosome chains. One of
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a low molecular weight DNA that freely dissociates from the nucleus, and one of a higher
molecular weight DNA, that remains bound. These apoptotic fractions contrast with the
very high molecular weight DNA from both fractions observed in normal cells that do not
even migrate on the gel. The contrasting results suggest that DNA fragmentation is
associated with apoptotic cell death [276].
Although, there have been studies where the signature DNA ladder was not
observed during apoptosis, these observations may be partially due to the method used in
detecting DNA fragmentation [278, 279]. Cell types that had previously not exhibited
DNA fragmentation during apoptosis were examined using a technique that selectively
amplifies blunt, 5’ ends by a modified ligation-mediated polymerase chain reaction. This
method resulted in DNA laddering o f all cell types tested after induction of apoptosis by
dexamethasone or UV irradiation. The cell types tested include normal thymic DNA, UV
irradiated P19 cells, genomic DNA from normal BALB/c mouse thymus, spleen, liver,
kidney, intestine, ovary, testes and brain, genomic DNA from D. melanogaster embryos
and M. Sexta intersegmental muscles, and the P5 cerebellum and P7 cortex from adult
and embryonic mouse. Although all tissues tested were positive for DNA fragmentation,
the adult brain had very low levels. This coincides with the lack of evidence for
apoptotic cell death in that tissue [280]. Thus, the DNA ladder may not be detected with
gel electrophoresis without prior amplification due to a lack of sensitivity, not because
DNA fragmentation did not occur.
Although DNA fragmentation is often referred to as a hallmark of apoptosis, it
has also been observed in necrotic cell death. In a study o f DNA degradation in apoptotic
and necrotic human leukemia cell deaths, the nuclear and mitochondrial DNA fractions
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were examined separately. Both of the necrotic fractions but only the nuclear fraction of
apoptotic cells resulted in DNA fragmentation. The mitochondrial DNA fraction from
the apoptotic cells appeared resistant to degradation [281]. These results indicate that
necrotic cell death also results in DNA fragmentation (although not in the organized
manner observed with apoptosis) and that the resistance of the apoptotic mitochondrial
DNA fraction may be a way to differentiate apoptotic and necrotic cell death. Further
evidence of DNA fragmentation in both apoptotic and necrotic cells was observed in a
study o f intracellular adenosine triphosphate’s effect on apoptosis and necrosis. Both the
apoptotic and necrotic cells exhibited DNA fragmentation during this study, although the
necrotic cells resulted in a lower level o f DNA fragmentation [282].
While there are several distinguishing characteristics between apoptotic and
necrotic cell death, both ultimately result in DNA degradation. This common feature of
cell death is exploited by using methods to id entify DNA strand breaks. Specifically, the
terminal deoxynucleotidyl transferase-mediated dUPT nick end labeling (TUNEL)
method has been shown to be an excellent tool for observing these DNA strand breaks.
This method is based on a protocol first developed in the early 1990’s by Frank R o sl due
to problems associated with agarose gel electrophoresis. These problems include the
insensitivity o f ethidium bromide staining and the time consuming labeling with 3Hthymidine and 32P that can also create high background signals in autoradiography when
trying to detect DNA fragmentation. The availability o f free 3’-OH ends resulting from
endonuclease cleavage, were end-labeled with only one nucleotide (to avoid false
positives by any nick-translation effect due to 3’-5’ exonuclease activity) such as 32PdCTP or 32P-dATP using a Klenow polymerase. The unincorporated nucleotides were
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removed and the resulting DNA was electrophoresed on a 1.8% agarose gel, the gel was
dried on 3MM Whatman paper and exposed for autoradiography [283]. This method has
since undergone several modifications such as the substitution of Klenow polymerase
with DNA polymerase or terminal deoxynucleotidyl transferase (TdT), and the
substitution of 32P-nucleotide labeling by fluorescein, digoxigenin, or biotin labeling.
These modifications opened the way for in-situ labeling of paraffin embedded sections
[284-286],
Although the TUNEL method was initially used to distinguish apoptotic cell
death, subsequent research has indicated it also detects DNA damage from necrotic and
autolytic cell death, cardiomyocytes undergoing active DNA repair and calcification of
matrix vesicles in atherosclerotic plaques [287-290]. Well-defined models o f apoptotic,
necrotic and autolytic liver cell death in rats were used to investigate the TUNEL assay.
All three types o f cell death resulted in TUNEL-positive staining o f nuclei. The autolytic
cells were the result of insufficiently fixed livers and could be avoided with optimal
fixation. These results indicated that DNA fragmentation is common to different types of
cell death [291]. TUNEL-positive staining o f apoptotic cells and necrotic cells was also
seen in tissue from frontal lobe contusions and verified using morphological criteria
[292]. These findings are consistent with numerous other studies demonstrating the
detection of DNA fragmentation in various cell types undergoing necrotic cell death
[289,291, 293, 294]. With regard to TUNEL-positive staining o f cardiomyocytes
undergoing DNA repair, both Laszlo Hegyi and the original authors independently
responded to Motoo Kanoh, et al.’s results. They both came to same conclusion that the
TUNEL-positive staining o f cardiomyocytes, that also stained positive for PCNA
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indicating DNA repair, was the result of severe DNA repair and would likely progress to
apoptosis [295,296]. The TUNEL-positive staining of calcified matrix vesicles in
atherosclerotic plaques can be avoided by pretrealment with a chelator such as EDTA
[297]. They can also be distinguished from apoptotic and necrotic cells by morphological
examination. Thus, the TUNEL technique is a sensitive molecular tool for investigating
cellular death whether from apoptosis or necrosis.

Benzidine

Benzidine (4,4 ’-diaminodiphenyl, 4,4 ’-dephenylenediamine and Fast Corinth
Base B) and its metabolites are widely studied carcinogens [8,269, 298-302]. It has been
classified as a Group A, human carcinogen by the Agency for Toxic Substance and
Disease Registry (ATSDR). The Environmental Protection Agency (EPA) lists benzidine
(BZ) as a hazardous air pollutant in the “Clean Air Act of 1990.” BZ is a polycyclic
arylamine and its chemical structure is that of a diphenyl with an amine moiety at both
the C4 and C4’ positions [303], It is a white, grayish-yellow, or reddish crystalline solid
or powder and usually present as benzidine hydrochloride or benzidine sulfate [304]. In
the environment it is either in its free form as an organic base or in a salt form such as
benzidine sulfate. In the air it is usually found attached to suspended particles [305]. BZ
is primarily used in the production o f azo dyes for the leather, textile, and paper
industries [304]. Exposure may occur from contaminated soils and groundwater. Health
effects

occur with both chronic and acute exposure, and range from dermal sensitivity to

liver, bladder and other cancers [20, 304].
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With regard to the environmental fate of and exposure to BZ, the EPA’s National
Priorities List (NPL) lists 1,408 hazardous waste sites as the most serious in the nation.
BZ has been identified in at least 27 of these NPL sites [305]. Human exposure to BZ
may occur at hazardous waste sites containing benzidine or in facilities that manufacture
or use benzidine. However, the general population’s potential risk of exposure, based on
available data, is almost nil [305].
Human exposure to benzidine has been researched through occupational
exposures and the use o f cultured cell lines. Bladder cancer have been reported in
workers with an occupational exposure to BZ, aniline, betanaphthylamine, and BZ-dyes
[44, 302, 306]. Studies of kimono painters exposed to BZ-based dyes by licking their
brushes revealed an increased risk of bladder tumors and bladder cancers [307]. A 22year study of a cohort o f 3,322 Japanese employees from plants manufacturing benzidine
and beta-naphthylamine a statistically significant risk for liver, gallbladder, and bile duct
cancers were found. From this study, 244 who had died o f cancer of the genitourinary
organs, 11 males also had primary liver, gallbladder, bile duct, large intestine, and lung
cancers [308].

Dermal sensitization to BZ was reported in 5% o f4,600 patients tested,

and of that 5%, 88.5% were diagnosed with occupational allergic contact dermatitis
[309].
Experiments investigating the effects of BZ have been conducted on various
animal models including hamsters, mice, rats, rabbits, grass frogs and dogs. The effects
from BZ varied depending on the organism tested. Neoplastic development due to BZ
exposure has been reported in rats, mice, hamsters, grass frogs, dogs and humans
(occupational studies) [305, 310, 311]. Liver neoplasms were observed in rats, mice,
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hamsters and humans upon exposure to BZ [308, 312-315]. Intermediate intragastric
exposure in female Sprague-Dawley rats (3.4 mg/kg/day x 3 days) to BZ was investigated
9 months after exposure and resulted in mammary carcinomas [316]. An inhalation study
using 28 rats exposed to 10-20 mg/m3 o f BZ dust, 4-hrs/day x 5 days/wk for 20 months, 5
developed myeloid leukemia, 4 had fibroadenoma, adenocarcinoma or squamous
carcinoma of the mammary gland and 1 with a hepatoma [304, 317]. Chronic exposure
studies in male BALB/c and female C57BL/6 mice revealed that doses of 1.8 to 2.5
mg/kg/day over their lifetime resulted in spongiform leukoencephalopathy, Harderian
gland adenomas and liver carcinomas in a number of the exposed mice [305, 318].
Hamsters fed 0.1% BZ base or BZ dihydrochloride in a lifetime study reported
occurrence o f malignant and benign multiple cholangiomas, hepatomas, and/or liver
carcinomas in >50% of those surviving [313], In dogs orally administered 17.6
mg/kg/day x 5 days of BZ for 5 years recurrent cystitis was observed, and at doses of
24.2 mg/kg/day x 6 day for the same duration, bladder carcinomas had developed [319],
Tumor induction at various sites by BZ is mostly species-specific and has been
attributed to species differences in metabolism ofbenzidine. The pathways for BZ
metabolism in various species have been correlated with acetylation at the nitrogen
position [301, 320, 321]. Species with efficient iV-acetylators are susceptible to liver
tumors and those that are deficient are susceptible to bladder cancer. This is seen with
humans polymorphic for N-acetylation, the slow acetylators who appear to have an
increased risk for bladder cancer [8 , 322]. A comparison o f human and rat hepatoma cell
lines with Chinese hamster lung-derived fibroblast cell lines, that have little or no
metabolic activity, resulted in sister chromatid exchanges in the hepatoma cell lines, but
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not in the fibroblast cell lines [8]. These results reflect a metabolic requirement for
induction of sister chromatid exchanges during exposure to BZ.
An in vivo study using high-pressure liquid chromatography (HPLC) identified 17
urinary and/or biliary metabolites of BZ in rats. The most potent mutagen o f these
metabolites was iV-hydroxy-diacetylbenzidine (A-OH-DABZ) with 10X greater potential
than A-actylbenzidine (ABZ) and N-N -diacetylbenzidine (DAB) and was also the major
metabolite at higher doses (50 mg/kg vs. 0.5-5 mg/kg) [323]. A study in rats identified
the metabolism of BZ to its reactive metabolite JV-OH-DABZ to include the A-oxidation
o f ABZ to iV’-OH-ABZ. The major pathway proposed for the formation of benzidine’s
reactive metabolites is: BZ —>ABZ —►iV’-OH-ABZ +-»iV-OH-DABZ. The authors also
confirmed the formation of the DNA adduct, 7V’-(deoxyguanosin-8-yl)-/Vacetylbenzidine, from iV-OH-DABZ in the presence o f N, (9-acyltransferase. They
additionally revealed the formation o f the same DNA adduct via a direct interaction with
iV’-OH-ABZ under acidic conditions [324].
Several studies have found correlations in the formation of DNA adducts with the
development o f tumors and neoplasms in carcinogenesis studies [325-329]. Formation of
DNA adducts have been associated with the induction of chromosomal aberrations in the
livers of mice after exposure to BZ. A linear dose response was demonstrated for BZDNA adducts with a correlation o f 0.91 between adduct levels and aberrations when
analyzed by dose groups [105]. Rat livers exposed to BZ also resulted in BZ-DNA
adduct formation, specifically the iV,-(3,-monophosphodeoxyguanosine-8-yl)-ABZ-DNA
adducts [330]. This formation of BZ DNA adducts and the resulting neoplastic
development in organisms exposed to BZ and it metabolites, indicate its potential for the
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early stages of polycyclic arylamine carcinogenesis studies in the western mosquitofish,
G. qffinis.

2-Amino fluorene

The arylamine, 2-amino fluorene (2-fluorenamine, 2-fluoreneamne and 9Hfluoren-2 -amine)), has also been widely studied in laboratories, although not as widely
studied as benzidine with regard to human exposures. 2-aminofluorene (2AF) is a white
to tan, solid, synthetic arylamine, not known to occur in nature, with a molecular weight
of 181.23, and is used in chemical research as an experimental carcinogen [331]. In
1940, 2-aminofluorene (2AF) was patented as an insecticide against the tobacco
homworm and that use discontinued a year later due to discovery o f its carcinogenicity
[332]. Numerous publications have since shown that the metabolic products of 2-AF are
mutagenic [269, 299, 333-336], 2-AF was the first chemical carcinogen to demonstrate
a direct metabolic conversion of a chemical to a more active form, 2 -acetylaminofluorene
(2-AAF) [337].
No data on long-term effects o f 2-AF exposure in humans was found in searches
of scientific journals or books. Genotoxic potency of 2-AF and several of its metabolites
was measured using the Drosophila DNA repair test with Drosophila melanogaster and
resulted in positives for DNA damage for 2-AF and all its metabolites tested [338].
Sister-chromatid exchanges were observed in a dose dependent manner in human
leukocytes exposed to 2-AF [103]. DNA-strands breaks were demonstrated in primary
mouse hepatocytes after administration o f 2-AF and its metabolites [339]. A study on
rats administered 1.62 mM/kg o f 2-AF and 2-AAF in their diets for 8 months resulted in
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a significant number of liver tumors, mammary gland tumors, ear duct tumors and small
intestine tumors in both treated groups [340]. In another study using mice, doses of
0.25% 2-AF in their diet for 326 days resulted in liver adenomas, hepatic hyperplasia,
bladder carcinomas and kidney carcinomas [341]. These and numerous other studies
have reported cancers resulting from dermal and oral administration o f 2-AF in both rats
and mice [342]. It is important to note that different species respond differently to
administration of 2-AF. Both monkeys and guinea pigs have not exhibited tumor
formation (the former may be due to experimental design). While liver and bladder
cancers are seen in dogs, mice and rats administered 2-AF, only liver tumors are seen in
chickens, fish, cats and hamsters, and only bladder tumors in rabbits.

Differences in the

metabolism of 2-AF are reported within a species such as mice and rats, along with
differences reported between the sexes [334, 343]. These studies intimate the importance
o f individual metabolisms in the conversion o f 2-AF to its reactive derivatives.
The metabolism of 2-AF in organisms varies between and within species and
more specifically tissues [334]. Intra-species variation w as also reported between male
and female rats, where male rats were more susceptible to 2-AAF toxicity, than were the
females [344]. The metabolism o f 2-AF has been extensively studied, along with the
formation o f DNA adducts fro m its DNA binding derivatives. The metabolites and
derivatives o f 2-AF that have been detected are 2-acetylaminofluorene (2-AAF), Nhydroxy-2-amino fluorene (A-OH-2-AF), A-hydroxy-2-acetylamino fluorene (A-OH-2AAF), N-A cetoxy-2-acetylam ino fluorene (A-acetoxy-2-AAF), A-sulfonoxy-2acetylam inofluorene

(A-SO4-2 -AAF), 1-hydroxy-2-acetylaminofluorene (l-hydroxy-2-

AAF) and (A-acetyl-A-2-fluorenylhydroxylamine p-D -gluconsid)uronate (A-GIO-2-AAF)
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[333]. Both of the jV-hydroxylated metabolites can be metabolized to the reactive Nsulfonoxy-2-AF and - 2-AFF by sulfotransferases. Noteworthy evidence supports the
role o f higher levels of sulfotransferase activity in males for the higher
hepatocarcinogenic response reported in male rats [345]. iV-hydroxy-2-AF and -2-AAF
are metabolized to the reactive N-Acetoy-2- AF by O-acetylase and N, O-acyltransferase,
respectively. The reactive metabolites jV-S04-2-AF and N-acetoxy-2-AF interact with
DNA form dG-C8 -AF adducts, while the N-SO4-2 -AAF reactive metabolite forms N(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG-C8 -AAF) and 3-(deoxyguanosin-A2yl)-2-acetylaminofluorene (dG-N2-AAF) DNA adducts [333, 342].
The formation o f DNA adducts in hepatic and urinary tract tissue after exposure
to 2-AF and its derivatives have been reported in dogs [334], 2-AF DNA adducts are
also reported in several cell lines: rat glial tumor cells, human malignant astocytoma and
brain glioblastoma multiform cells, human colon tumor cells, human bladder tumor cells,
human leukemia cells, and human lung tumor cells [346-353]. Syrian hamsters
consistently produced higher 2-AF DNA adduct levels in the liver than in the bladder [9].
Studies that have compared DNA adduct levels from 2-AF and its metabolites in various
tissues usually found the highest incidence to occur in livers, however, route of
administration and sex of the animals appear to have an influence DNA binding levels in
different tissues [333]. As with BZ, 2-AF DNA adduct formation and neoplastic
development after exposure to 2-AF and its derivatives are excellent candidates for early
carcinogenesis studies. Its use as a potential molecular tool, for the investigation o f the
effects of polycyclic arylamine carcinogenic studies in G. qffinis, is examined in this
study.
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Gambusia afFmis

Aquatic Species in Carcinogenic Studies
Neoplasms have been reported in fish since as early as 1793 when multiple
osteomas were found in the butterflyfish (Plataxpinnatus) [30, 354]. Numerous studies
have since reported neoplasms in bony and cartilaginous fish in both fresh- and salt-water
species [355-358]. However, it wasn’t until the late 1970’s and early 1980’s that the use
of aquatic species in environmental carcinogenic studies became o f national interest. In
August o f 1978, the EPA and NCI collaborated on a program to study and develop
aquatic organisms for carcinogenicity studies. An additional interagency agreement was
initiated between the U.S. Army Medical Research and Development Command and the
EPA to develop more sensitive, shorter term, and less expensive monitors for evaluating
environmental pollutants and their health effects using two fish species [359].
These collaborative efforts have revealed that fish have metabolic pathways
similar to mammals, develop neoplasms in laboratory settings that have been reported to

develop in relatively short time periods, exhibit hardiness under experimental conditions
and are easily maintained [26, 360, 361]. In addition to these benefits of using fish in
carcinogenic studies, is the often overlooked, yet profound importance o f the usefulness
of aquatic species in monitoring the overall health o f an environmental setting.
For example, an investigation of environmental carcinogenesis in fishes of the
Great Lakes was conducted from 1973-76 and occurrences of neoplasms were found to
be associated with polluted versus non-polluted areas [362]. Epizootiologic studies in
Burlington Harbour (a heavily polluted bay due to industrial and domestic effluents) on
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Lake Ontario revealed increased tumor frequency in Burlington Harbour and Oakville
Creek white suckers that decreased significantly in collections made at varying distances
in both directions from this region [363, 364], Also, a high prevalence of hepatic
neoplasms was reported in mummichog from a PAH-contaminated site in the Elizabeth
River [365], Contaminated waters not only affect the organisms residing in them, they
also impact the organisms surrounding them. An example is the statistically significant
associations that were found between cancer mortality rates in white males in Louisiana
and drinking water obtained from the Mississippi River [366]. Therefore, these studies,
along with numerous others studies indicate the considerable utility o f aquatic organisms
as sentinel animals for biomonitoring in the early detection of environmental carcinogens.
While histologic investigations have shown the utility o f aquatic organisms in
tumor formation and cancer development, molecular studies have further advanced their
utility in carcinogenic studies. This is demonstrated in DNA adduct analysis
investigations. These DNA adduct studies have been conducted on small fish models in
carcinogenic studies and have demonstrated the formation o f DNA adducts with exposure
to carcinogens [17, 28, 32, 367], Although molecular and immunologic applications with
fish lag behind mammals, it has been found that most reagents and procedures used in
mammalian research can also be used with fish [368].

Gamhusia Affinis in Environmental Carcinogenesis Studies

A variety o f fish species are used in environmental carcinogenesis studies
including rainbow trout, medaka, guppy, sheepshead minnow, zebrafish, and the western
mosquitofishjust to name a few of the different fish species used in research [29, 34, 365,
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368-376]. While the rainbow trout, medaka, and zebrafish are probably the most highly
characterized in research, it is the geographic ubiquity o f the western mosquitofish
(Gambusia affinis) that makes it stand-out as an aquatic sentinel species for
environmental biomonitoring. The limited geographic distribution of several small fish
species studied imposes restrictions for direct biomonitoring for these species in diverse
environmental settings. Additionally, G. affinis are not a migratory fish and can be used
to biomonitor specific ranges [27]
The widespread geographic locations o f G. affinis are attributed to its hardiness in
hostile environments. They are able to tolerate a variety o f waters from that o f high
quality to harsh conditions. A recent study o f its survival in a hostile environment,
revealed a salinity tolerance above that of frill sea water, >10 ppm ammonia, >100 ppm
nitrates and <1 ppm O2 [377]. G. affinis has been used as an aquatic model o f choice for
toxicity studies o f pollutants to fish in several investigations [378-380]. In a study
examining the histopathological effects of Thiodan® on G. affinis livers, numerous
morphological changes were observed ranging from vacuolization of cell cytoplasm and
infiltration o f lymphocytes to pycnotic state o f nuclei and degeneration of cells [380].
DNA strand breaks have also been observed in G. affinis inhabiting retention ponds
heavily contaminated with radionuclides [381].
It has also been demonstrated that they develop hepatocarcinomas after relatively
short exposures to methylazoxymethanol acetate, [27]. The development of neoplasms in
the liver of G. affinis is important to its usefulness as a sentinel species for environmental
biomonitoring. Correlational evidence o f a relationship between contaminant exposure
and hepatic neoplasms and related lesions are useful histopathological biomarkers o f
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contamination exposure effects [382]. While hepatic neoplasms have been observed in
G. affinis after exposure to methylazoxymethanol acetate, there exists a need for
examining the effects of other compounds and their mixtures on these fish to ascertain
their responses to other carcinogens of different mechanistic classes [27]. Thus, the
polycyclic arylamines, BZ and 2-AF, which have conclusively shown DNA adduct
formation and neoplastic development in the livers of several species tested and are
examined here for their effects on cellular proliferation and death, along with
histopathological observations in the liver’s of G. affinis.
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CHAPTER m

MOLECULAR TOOLS

Purpose of Investigating Molecular Tools

Molecular tools (biomarkers) have made an extraordinary contribution to
biological research by allowing investigators to visualize microscopic phenomena taking
place at cellular and molecular levels. These tools can range from enzyme assays of
molecular events to immunoassays of protein levels. The molecular tool of interest here
is immunological assays o f proteins. Antibodies are used in research to 1) measure
minute amounts of a material, usually proteins, in a complex mixture, 2 ) to detect specific
proteins in gels, tissues and cell cultures 3) or to isolate a specific protein in a complex
mixture [383]. While the use o f antibodies in research has lead to great advancements in
our understanding o f biological processes, they are usually developed against a particular
species and therefore restrictive in their use. Typically, the species is a highly
characterized organism in scientific literature. In less investigated animal models, this
pool of molecular tools is even more limited. Human, mouse and rat antibodies are by far
the more abundant antibodies commercially available.
Since G, affinis is our animal model o f choice, for the reasons stated in the
literature review, and is not a popular animal model in research, there are no speciesspecific antibodies for cellular proliferation or death commercially available. However,
all is not lost. Fortunately, evolutionarily highly conserved proteins in one organism
often contain the same antibody recognition site as the related protein in another
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organism [191]. This permits the use o f an antibody developed for one animal model to
be used in another unrelated animal model.
With that in mind, this experiment tests the specificity of antibodies to conserved
proteins in unrelated species (rat or human) against four of the same type of proteins from
G. affinis. The antibodies being tested here are against PCNA, p53 and cleaved caspase3 and PARP proteins. PCNA protein is involved in cellular proliferation while p53 and
cleaved caspase-3 and PARP proteins are both involved in cellular death (see literature
review). The conserved nature of these proteins was verified using protein sequences
obtained from the Swiss-Protein/TrEMBL web site. The sequences were compared
between all sequence-available non-related species using the Blast sequence alignment
tool. All four proteins had a high degree of sequence homology with non-related species,
indicating the conserved nature of these proteins. To determine whether these antibodies
bind specifically to the protein o f interest, and only to that protein, western blots were
conducted for each antibody.

Experimental Design

This experiment is designed to demonstrate the antibody specificity o f rat specific
anti-PCNA, mouse specific anti-p53, and human specific anti-cleaved caspase-3 and
PARP antibodies on G. affinis PCNA, p53, caspase-3 and PARP proteins. Therefore, 10
male G. affinis were randomly selected and half were placed in a glass bowl containing a
liter o f filtered water for 2 days, while the other half were placed in a glass bowl
containing a liter of filtered water and 50 ppm carbon tetrachloride, to induce liver injury,
for 4 hrs, then transferred to a glass bowl containing a liter o f filtered water for 2 days.
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Once treatment w as complete, fish were immediately processed for total protein
ex tractio n

and quantification using the micro Lowery method, and western blot analysis

o f antibody specificity.
To ensure the accuracy of carrying out the experimental procedures and the
integrity o f the reagents, internal controls were used. For internal controls, AML12
proliferating mouse hepatocytes (ATCC, Manassas, VA) were cultured in Coming tissue
culture dishes (VWR Scientific, South Plainfield, NJ) in Vitacell F-12K medium (ATCC,
Manassas, VA) supplemented with 10% fetal bovine serum and 0.1 % penicillinstreptomycin solution (Sigma Aldrich, St. Louis, MO) and incubated in 5% CO2 at 37° C.
Culture media was replaced every 2 days until confluency was attained. Half of the cells
were incubated at 37° C for 8 hrs while the other half were treated with 20 pM
camptothecin (Genotech, St. Louis, Mo) in medium, to induce apoptosis, and incubated at
37° C for 8 hrs. When treatment was complete, cells were detached from the culture
plates using 2 ml 0.25% trypsin (ATCC, Manassa, VA) and suspended in culture
medium. Samples from the cell suspensions were processed to test for live cells, necrotic
cells and apoptotic cells by flow cytometry and bright field and phase contrast
microscopy. This was followed by total protein extraction of the suspended cells, protein
quantification, and use as internal controls in western blot analysis.

Methods and Materials

Fish and Housing

G. affinis were purchased from Aquatic Research Organisms, Hampton, NH, and

treated in accordance with an animal use protocol (99-06-02) approved by the
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Institutional Animal Care and Use Committee of Western Michigan University. They
were housed in 10-gallon aquariums in a flow-through dual filtered water aquaria system.
The dual filtration system shown in Figure 2 consisted of an iron filter for iron removal
before an activated carbon filter for chlorine removal. Filtered water and air were
circulated through CPVC piping and delivered to the appropriate aquaria as shown in
Figure 3. Bulkheads were attached to each aquarium for water drainage in order to
maintain water levels while water was continually fed to the aquarium as in Figure 4.
Drainage water filtered through a tub of activated carbon, as seen in Figure 5, before
entering floor drain. Aquarium water temperature was maintained at 76-78° C and light
cycled at 12 hrs on and 12 hrs off. General health was monitored daily, while alkalinity,
ammonia, pH, dissolved 0 2, C02, nitrites, chloride, chlorine and hardness o f the aquaria
water was monitored on a weekly basis. Fish were fed freshwater aquarium flake food,
approximately 1% o f their averaged weight, twice daily from automated fish feeders.

Figure 2. Dual Filtration System.
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Figure 3. Circulating Air and Water Through CPVC Piping.

mB^BBBB

Figure 4. Bulkhead Attachment for Continual Water Drainage.
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Figure 5. Filtration of Drainage Water.

When treatments were completed, fish were sacrificed by placing on ice for 45 min and
decapitation before tissue was removed.

Flow Cytometry. Fluorescence Microscopy and Differential Interference Contrast
Microscopy
Flow cytometry and microscopy are frequently used to differentiate live, necrotic
and apoptotic cells, based their biochemical and/or morphological characteristics [384390]. Fluorescent dyes specific for the detection of live, necrotic and apoptotic cells,
were used here on samples from treated and non-treated AML hepatocytes, and examined
on a BD LSR flow cytometer (BD Biosciences, San Jose, CA) and a Nikon MicrophotFXA upright microscope (Nikon Inc., Tokyo, Japan). Flow cytometry measures the
intensity of fluorescence emitted by the stained cells and translates these fluorescent
signals into electronic signals that interface with a computer for data transfer. The
resulting data is represented in histograms created in the Cell Quest software package
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(BD Biosciences, San Jose, CA). These results will be utilized to characterize AML12
hepatocytes as internal controls in the western blotting analysis.
Morphological verification of apoptosis is always recommended due to the
possibility of non-specific binding o f the fluorochromes [387, 391-394]. Therefore,
fluorescence microscopy and differential interference contrast (DIC) microscopy were
used to verify apoptosis. This allows for the visualization of individual cells in the
sample. Fluorescence microscopy was used to identify fluorescing cells and DIC
microscopy to visualize the apoptotic morphology of the fluorescing cell.

Cell Staining

Three fractions o f the AML12 hepatocytes were prepared for fluorochrome
staining, one fraction was live untreated cells, the second fraction subjected to 3
freeze/thaw cycles to induce necrotic cell death and the third fraction contained
camptothecin-induced apoptotic cells. These cell suspensions were all labeled with 1
pl/ml propidium iodide staining solution for 10 min (Biosure, Grass Valley, Ca).
Propidium iodide binds DNA, but does not cross the plasma membrane efficiently and is
used to differentiate live and apoptotic cells from dead cells because the dead cells have
fragmented membranes [388]. To differentiate the live cells from the apoptotic cell
suspensions, the live and apoptotic samples were stained with 30 ul/ml Hoechst 33324
(Molecular Probes, Eugene, OR) for 30 min. Hoechst 33342 also binds DNA, however it
is rapidly taken up by the increased membrane permeability o f apoptotic cells for that dye
[395, 396],
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Flow Cvtometrv

The flow cytometer was calibrated using SPHERO™ rainbow blank and
fluorescent calibration particles (Pharmingen, San Diego, CA) and Align Flow™ 633 mm
and UV beads (Molecular Probes, Eugene, OR). Once the AML12 hepatocytes were
stained, 1 ml from each o f the live, necrotic, and apoptotic cell suspensions were
analyzed by flow cytometry. The detection o f propidium iodide fluorescence was
measured on the flow cytometer using a 488 nm argon laser, while Hoechst 33342
fluoresence was detected with the 325 nm Helium/Cadmium UV laser. The detector
settings for forward and side scatter were set at liner amp gain, and all other detectors set
at log amp gain. Ten thousand events were collected on the flow cytometer for each of
the cell samples.

Fluorescence Microscopy and DIC Microscopy

Immediately after flow cytometry, a drop of each of the stained cells was placed
on glass slides and observed using the Nikon-FXA epi-fluorescent research microscope
with a 100-watt mercury light source (Nikon Inc., Tokyo, Japan). The red (propidium
iodide) fluorescence was observed using a G-2A filter cassette to identify dead cells and
the blue (Hoechst 33342) fluorescence was observed using a UV-1A filter cassette to
differentiate apoptotic cells from live cells. Immediately following fluorescence
detection of red (dead), dim blue (live), or bright blue (apoptotic) cell samples with the
epi-fluorescent microscope, the cells were observed using DIC microscopy. DIC
microscopy was used to identify the morphological characteristics o f live, necrotic and
apoptotic cells. Once it was verified that the three fractions of cells were live, necrotic,
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and apoptotic cells, the AML12 hepatocytes were processed for western blotting as
internal controls.

Western Blots for Immunodetection of PCNA. p53 and Cleaved Caspase-3 and
PART Proteins
Western blotting of protein extracts is an established method for immunodetection
of specific proteins contained in a complex protein extract [397, 398]. This techniqe
allows an investigator to determine whether a particular protein of is expressed in the
cells or tissue o f interest. Western blotting exploits the differential electrophoretic
mobility of proteins. Proteins are isolated from cells or tissues and loaded into wells on a
polyacrylimide gel. The gel is the electrophoresed and the proteins are separated by size.
Smaller proteins will migrate further through the porous gel than the larger proteins.
Once separated, proteins on the gel are transferred to a membrane using an electrical
current. The membrane is then incubated with a primary antibody against the protein of
interest. After incubation with the primary antibody, it is labeled with a horseradish
peroxidase (HRP)-conjugated secondary antibody against the primary antibody. These
antibody complexes are then incubated with a light emitting chemiluminescent reagent.
The membrane is then exposed to x-ray film for chemiluminescent detection using ETC™
reagents (Amersham Biotech, Arlington Heights, EL). This detection is the result of
photons emitted from the antibody complexes bound to the membrane and exposed to an
x-ray film where these photon emissions are captured. The resulting x-ray film is
developed and any dark dots or bands that are recorded on the film are used for analysis
of protein/antibody complexes.
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Total Protein Extraction and Quantification

The livers of non-treated and carbon tetrachloride treated G. affinis were
immediately removed upon sacrifice, homogenized in a 7 ml Dounce tissue grinder
(VWR International, South Plainfield, NJ), rinsed 3x in PBS and suspended in 5-10 ml
PBS. Non-treated and camptothecin treated AML12 hepatocyte suspensions were also
rinsed 3x in PBS and re-suspended in 5-10 ml PBS. Both G. affinis and AML12
hepatocyte cell suspensions were centrifuged at 10K rpm for 5 min and the resulting
pellet was collected, by pouring off supernatant, and resuspended in 5-10 ml PBS (this
was repeated 2x). Total protein was extracted from the G. affinis and AML12 hepatocyte
cell suspensions using Chaps cell extract buffer (Cell Signaling, Beverly, MA) in
accordance with manufacturers protocol. Total protein extract was then quantified using
the Micro Protein Determination kit (Sigma Aldrich, St. Louis, MO), based on a modified
Lowery technique, in accordance with manufacturers protocol.

Western Blotting

Protein separation was carried out by gel electrophoresis with Novex’s NuPage
gel system (Invitrogen, Carlsbad, CA), in their precast 4-12% gels with MES buffer. 30
pg total protein from non-treated and carbon tetrachloride treated G, affinis liver extracts
and non-treated and camptothecin treated AML12 hepatocyte extracts, along with 5 pis
SeeBlue® pre-stained protein standard (Invitrogen, Carlsbad, CA) were added to sample
buffer (15 pis total volume), and loaded into the wells, then ran in an X-Cell II mini cell
(Invitrogen, Carlsbad, CA) at 100 V for 1.5 hrs. The gel was removed from the cassette
for protein transfer to a nitrocellulose membrane (0.45 pm pore size) using membrane
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filter sandwich packs with Novex’s NuPAGE transfer buffer (Invitrogen, Carlsbad, CA)
in an X-cell II blot module transfer apparatus (Invitrogen, Carlsbad, CA) and ran at 30 V
for 1 hr. Membranes were removed and non-specific sites blocked by incubation in 5%
BSA/TBS-T overnight at 4° C. Membranes were then washed 4 times for 15,10,10 and
5 min each in TBS-T on a rocking platform. Individual membranes were each incubated
in one o f the 4 primary antibodies; 1) mouse anti-PCNA antibody against rat PCNA,
PC10 clone (Dako, Carpinteria, CA), 2) mouse anti-p53 antibody against human p53, Pab
240 clone (BD Immunocytometry, San Jose, CA), rabbit anti-cleaved caspase-3 (Aspl75)
polyclonal antibody and mouse anti-cleaved PARP (Asp214) monoclonal antibody
against human cleaved caspase-3 and PARP, respectively (Cell Signaling, Beverly, MA)
at optimized dilutions in TBS-T for 2 hours at room temperature. Membranes were
washed 4 times for 15,10,10 and 5 min each in TBS-T on a rocking platform. Incubated
membranes in the appropriate mouse or rabbit HRP-secondary antibody supplied in the
ECL™ western blotting detection reagents (Amersham Bioscience, Arlington Heights, IE)
at a 1:1000 dilution in TBS-T for 1 hr at room temperature. Washed membranes as
before, and followed manufacturer’s protocol for ECL™ western blotting detection
reagents for detection o f blots on XAR-5 X-OMAT x-ray film (VWR Scientific, South
Plainfield, NJ). X-ray film was developed and fixed using GBX Developer and GBX
Fixer (Sigma Aldrich, St. Louis, MO).
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Results

Flow Cytometric Analysis o f AML 12 Hepatocytes

To verify use o f the AML12 hepatocytes as internal controls for western blotting,
AML12 hepatocytes were stained with either propidium iodide or Hoechst 33342 and
subjected to flow cytometry. Propidium iodide stain was used to identify cells
undergoing necrotic cell death and Hoechst 33342 stain was used to differentiate live
cells from apoptotic cells. Flow cytometric analysis of the AML12 hepatocyte fractions
stained with propidium iodide is represented in histograms in figures 6 -8 . Propidium
iodide staining was most intense in the histogram o f the freeze/thawed hepatocytes,
figure 6, with a peak of approximately 120 counts in channel 103. The camptothecin
treated cells, Figure 7, peaked at around 20 counts and the non-treated hepatocytes,
Figure 8 , around 40 counts in channel 103. Thus, propidium iodide staining was most
intense in the freeze/thawed AML12 hepatocytes indicating necrotic cells. The two
remaining fractions, the non-treated and camptothecin treated fractions were further
examined by flow cytometry for differentiation.
Flow cytometry of the Hoechst 33342 stained camptothecin treated and nontreated AML12 hepatocytes is represented in Figures 9 and 10 respectively. The Hoechst
33342 stained camptothecin treated AML12 hepatocytes revealed fluorescence with a
peak o f about 160 in channel 10 1, while the non-treated hepatocytes fluoresced to a lesser
degree at around 100 in channel 101. This is indicative o f the increased uptake of
Hoechst 33342 in apoptotic cells when compared to live cells. Additional examinations
o f the three AML12 hepatocyte cell fractions were conducted using fluorescence and DIC
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microscopy to confirm the flow cytometric analysis.

Fluorescence Microscopy and DIC Microscopy of AML 12 Hepatocytes

Further examination of the three AML12 hepatocyte fractions using the NikonFXA epi-fluorescence microscope with the G-2A filter cassette for propidium iodide’s
red fluorescence revealed that the vast majority of cells from the freeze/thawed
hepatocytes were fluorescing red. This was in contrast with the significant decrease in
red fluorescence from the non-treated and camptothecin treated AML12 hepatocytes.
These samples were immediately observed using DIC microscopy. The red fluorescing
cells demonstrated a typical necrotic morphology including membrane discontinuities,
cellular swelling and loss of cellular contents. These were numerous in the freeze/thawed
hepatocytes and rare in the camptothecin treated and non-treated hepatocytes. The two
remaining fractions, the non-treated and camptothecin treated fractions were further
examined by fluorescence and DIC microscopy for differentiation.
For further differentiation o f the non-treated and camptothecin treated AML12
hepatocytes, fluorescence microscopy with the UV-1A filter cassette was used to identify
Hoechst 33342’s blue fluorescence. The camptothecin treated AML12 hepatocytes
revealed a significant number of cells with intense blue fluorescence, while the nontreated AML12 hepatocytes contained a large number of cells fluorescing a dim blue
fluorescence. DIC microscopy of these samples further differentiated the bright blue
fluorescing hepatocytes from the dimly fluorescing hepatocytes. The major observation
differentiating these two fractions of AML12 hepatocytes was the significant membrane
blebbing observed in the bright blue fluorescing cells that was not seen in the dim blue
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Figure 6 .

Flow Cytometry Histogram of Propidium Iodide (PI) Stained Freeze/Thawed
AML12 Hepatocytes.

Piped}
Figure 7.

Flow Cytometry Histogram o f Propidium Iodide (PI) Stained Camptothecin
Treated AML12 Hepatocytes.
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Figure 8 .

Flow Cytometry Histogram o f Propidium Iodide (PI) Stained Non-Treated
AML12 Hepatocytes.
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Figure 9.

Flow Cytometry Histogram o f Hoechst 33342 Stained Camptothecin Treated
AML12 Hepatocytes.
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Figure 10.

Flow Cytometry Histogram of Hoechst 33342 Stained Non-Treated AML12
Hepatocytes.

fluorescing cells. The dim blue fluorescing cells had intact membranes without
observable blebbing. These results from fluorescence microscopy and DIC microscopy

Western Blots ofPCNA. p53. and Cleaved Caspase-3 and PARP

The western blot technique has been used extensively in scientific research for
separating and detecting proteins by antibody recognition [399-408]. Therefore, western
blot analysis was employed here for the detection o f G. affinis PCNA, p53 and cleaved
caspase-3 and PARP proteins by respective antibodies. Western blot analysis ofPCNA
antibody against human PCNA was examined for specificity against G. affinis PCNA
protein is shown in Figure 11. Lanes are designated as follows: lanes 1) and 2), carbon
tetrachloride treated and non-treated G, affinis protein extracts, respectively, lanes 3) and
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4), camptothecin treated and non-treated AML12 mouse hepatocyte protein extracts,
respectively, lane B), blank and the last lane is Magic Mark protein standard (Invitrogen,
Carlsbad, CA) with kilo-Daltons indicated on the right. There is some shadowing effect
from movement of the membrane on the film. This blot revealed a band at approximately
32-36 kDa in both the carbon tetrachloride treated and non-treated G. affinis protein
extracts. This 32-36 kDa band corresponds with the same band observed for both the
camptothecin treated and non-treated internal controls. These results correlate well with
those observed in scientific literature where PCNA protein is demonstrated to be a 28-36
kDa protein depending on the species examined [180, 409].
The anti-p53 antibody against humans was tested for specificity against G. affinis
p53 protein as shown in figure 12. The lanes are designated as follows: lanes 1) and 2),
non-treated and camptothecin treated AML 12 mouse hepatocyte protein extracts,
respectively, lanes 3) and 4) non-treated and carbon tetrachloride treated G. affinis
protein extracts, respectively, and the last lane contains SeeBlue® Plus2 protein standard
(Invitrogen, Carlsbad, CA) with kilo-Daltons indicated on the right. Protein standard is
cut and pasted from the original membrane. This blot resulted in an approximately 98104 kDa band for both the carbon tetrachloride treated and non-treated G. affinis samples,
with a comparatively stronger signal in the treated group. Blots of the internal controls
both contained the expected 54-56 kDa band, however, the camptothecin treated group
had two additional bands at approximately 85 and 48 kDa’s. The results from the G.
affinis protein samples deviated from the size of the p53 protein reported in literature.
The band size expected was around 42 - 53 kDa [216, 410].
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Anti-cleaved caspase-3 antibody against human cleaved caspase-3 was used to
test specificity against G, affinis cleaved caspase-3 protein. These results are represented
in Figure 13. Lane designation is as follows: lanes 1) and 2), carbon tetrachloride treated
and non-treated G. affinis protein extracts, respectively, lanes 3) and 4), non-treated and
camptothecin treated AML12 mouse hepatocyte protein extracts, and the last lane is
SeeBlue® protein standard (Invitrogen, Carlsbad, CA) with kilo-Daltons indicated on the
right. Protein standard is cut and pasted from the original membrane. This western blot
revealed a band at about 36 kDa in both the carbon tetrachloride treated and non-treated
fish groups. No signal was detected from either o f the AML12 hepatocyte internal
controls. These results were not aligned with those published in literature. The size
expected of the cleaved caspase-3 fragment should be around 17-22 kDa while the fulllength caspase-3 is typically around 32-38 kDa [252, 411-414].
The anti-cleaved PARP antibody (against human cleaved PARP) was used to
examine its specificity to G. affinis PARP protein. The results are shown in Figure 14.
Lanes are designated as follows: lanes 1) and 2), carbon tetrachloride treated and nontreated G. affinis protein extracts, respectively, lanes 3) and 4), camptothecin treated and
non-treated AML12 mouse hepatocyte protein extracts, respectively, and the last lane is
SeeBlue® protein standard (Invitrogen, Carlsbad, CA) with kilo-Daltons indicated on the
right. Protein standard is cut and pasted from the original membrane. This western blot
revealed one band of approximately 40-42 kDa in the carbon tetrachloride treated fish
samples with an identical, but weaker band, observed in the non-treated group. The
AML12 hepatocytes resulted in an approximately 100-115 kDa band in the non-treated
group and an 85-90 kDa band in both the camptothecin treated and non-treated samples.
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Figure 11.

Western Blot o f Anti-PCNA Antibody Labeling of Total Protein Extracts.

4 9

Figure 12.

Western Blot o f Anti-p53 Antibody Labeling o f Total Protein Extracts.
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Figure 13.

Western Blot of Anti-Cleaved Caspase-3 Antibody Labeling of Total
Protein Extracts.

la s s

Figure 14.

Western Blot of Anti-Cleaved PARP Antibody Labeling of Total Protein
Extracts.
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Although the results from the G. affinis samples do not correspond with that described in
literature, the internal controls were as expected with the full length PARP at 113-116
kDa and the large cleaved fragment at 85-89 kDa as demonstrated in numerous
publications [128,216,252, 255,267,412].

Discussion

The integrity of AML12 proliferating mouse hepatocytes for use as internal
controls in western blot analysis was examined here. The internal controls had two major
requirements: 1) they had to proliferate, and, 2) they had to be capable of being induced
to undergo apoptosis. The reasoning behind these requirements is that the antibodies that
will be used in the western blots are against proteins involved in proliferation and
apoptosis. AML12 hepatocytes are naturally proliferating cells, however, apoptosis has
to be induced. Flow cytometric analysis, along with fluorescence and DIC microscopy
demonstrated that the AML12 hepatocytes could be induced to undergo apoptosis when
treated with camptothecin and that this could be differentiated from necrotic cells and
live cells.
Apoptotic and live cells were differentiated from necrosis by staining the cell
fractions representing live (non-treated), necrotic (3 freeze/thaws) and apoptotic
(camptothecin treated) cells with propidium iodide and examining with flow cytometry.
Flow cytometric analysis resulted in a high intensity o f red fluorescence in the
freeze/thawed cells, Figure 6. In contrast there was minimal fluorescence o f the other
two fractions, Figures 7 and 8. Propidium iodide is basically impermeable in cells with
intact membranes. Necrotic cells have fragmented plasma and nuclear membranes that
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result in greater staining of their nucleic acids by propidium iodide [164, 391]. The nontreated and camptothecin treated cells exhibited a very low degree of propidium iodide
staining, indicating that necrosis was minimal in these cells.
These results were further examined with fluorescence and DIC microscopy.
Using fluorescence microscopy, the red fluorescence of the freeze/thawed hepatocyte
fraction was observed in the majority o f cells. Only a few cells from the non-treated and
camptothecin treated hepatocytes were fluorescent. When these samples were examined
with phase contrast microscopy, they revealed morphological characteristics o f necrosis
in the fluorescing cells. The morphological characteristics ranged from cellular swelling
and membrane fragmentation to complete cellular degradation. These results indicated
that the cells induced to undergo necrosis were indeed necrotic cells and that the other
cells did not experience any appreciable necrosis.
The non-treated and camptothecin treated AML12 hepatocytes were stained with
Hoechst 33342 to verify induction of apoptosis in the camptothecin treated cells. After
staining the cells with Hoechst 33342, flow cytometric analysis differentiated the two
fractions as live and apoptotic by the intensity o f their blue fluorescence. The blue
fluorescence from Hoechst 33342, which is readily taken up by apoptotic cells, was much
more intense in the camptothecin treated hepatocytes than in the non-treated cells as
shown in Figures 9 and 10, respectively. This suggests that the camptothecin treated cells
were apoptotic, but not the non-treated cells. Fluorescence microscopy correlated well
with the flow cytometric results. A significant proportion o f cells from the camptothecin
treated AML12 hepatocytes fluoresced bright blue, while the majority o f non-treated
AML12 hepatocytes fluoresced a dim blue. Examination of these cells by DIC
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microscopy revealed morphological characteristics of apoptosis in the brightly stained
cells. Cellular condensation was noted, however, most significant, was the membrane
blebbing observed in the bright blue fluorescing hepatocytes. These results, from flow
cytometric analysis, fluorescence microscopy and DIC microscopy combined, indicate
that the AML12 hepatocytes meet the major requirements for use as internal controls in
western blot analysis. While their proliferative state is self-evident, this experiment
verified induction o f apoptosis in the AML12 hepatocytes exposed to camptothecin and
differentiated them from necrotic cells and live cells.
These results were imperative for western blot detection of p53, cleaved caspase-3
and PARP, along with PCNA in AML12 hepatocytes for use as internal controls in their
respective western blots. Since apoptosis could be induced in the AML12 hepatocytes, it
follows that the apoptotic cells would have elevated levels o f the apoptosis related
proteins, p53 and cleaved caspase3 and PARP. Additionally, the proliferative state of
AML12 hepatocytes results in elevated levels ofPCNA protein. Thus, these hepatocytes
meet the requirements put forth to ensure the integrity o f the procedures and reagents
used in western blotting.
Western blot analysis was employed for determining antibody specificity of
PCNA, p53 and cleaved caspase-3 and PARP antibodies against the respective proteins
from G. affinis. While results from the p53 and cleaved capsase-3 and PARP western
blots were inconclusive, definitive PCNA antibody specificity against G. affinis PCNA
was revealed. This was demonstrated in the western blot, figure 11, by the appearance of
32-36 kDa bands in both the carbon tetrachloride treated and non-treated G. affinis
protein extracts. PCNA antibodies have been previously employed in
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immunohistochemical detection of G. affinis PCNA [27]. The use ofPCNA in
immunohistochemical detection of proliferating cells in G. affinis correlates with the
presence of proliferating cells such as intestinal crypt cells, cells in the gill filament and
highly mitotic regions of the testis [373]. However, after an extensive search, this author
was unable to find any references to western blot analysis o f antibody specificity against
G. affinis PCNA in scientific literature. Therefore, this study validated that the antigenic
properties of G. affinis PCNA protein is specific for and compatible with the PC 10 clone
antibody against rat PCNA and that non-specific antibody labeling does not take place.
The antigenic properties of G. affinis p53 and cleaved caspase-3 and PARP
proteins, however, were not as clear with regard to antibody specificity. The western blot
using p53 antibody against human p53 ideally would have produced a band of around 4253 kDa, This molecular weight range was determined by previously published research
in scientific literature and the p53 protein sequences listed in the Swiss-Prot/TrEMBL
protein database, accession numbers P79734, Q29537, P02340, P25035 and P04637
[415-417]. The molecular weight of the product observed in the G. affinis western blot
was around 98-104 kDa, Figure 12, which is double the expected product. Whether or
not some complexed form o f p53 protein produced this band size is unknown.
The molecular weight o f cleaved caspase-3 is typically 17-22 kDa and its pro
form ranges from 32-38 kDa as observed in several studies as reported in the Swiss
Prot/TrEMBL database, accession numbers P42574, P70677, P55866 and P04637 [414,
418-420]. While it appears that the 36 kDa band on the G. affinis western blot, Figure
13, detected the full-length form the cleaved form was not observed. This may be
indicative of low levels of cleaved caspase-3 or a caspase-3 independent apoptotic
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pathway in carbon tetrachloride treated G. affinis liver cells. Confounding this, the
internal controls did not produce any bands on the blots. Several optimization steps for
protein concentration, primary antibody and secondary antibody dilutions and incubation
times did not have any effect. Therefore, the integrity o f the reagents and procedures
could not be verified. Although further experimentation is necessary, the recognition of
an approximately 36 kDa protein in the G. affinis blots may be for the pro-form of
caspase-3.
The molecular weight o f cleaved and full-length PARP has been established as
85-89 kDa for the large cleaved PARP fragment and 113-116 kDa for the pro-form [257,
420-422]. The PARP western blot of G. affinis proteins revealed a 40-42 kDa product,
Figure 14. While this product may reflect an additional cleavage ofPARP in G. affinis,
further experimentation is necessary. To examine this discrepancy in the PARP western
blot, along with the observed discrepancies in the p53 and cleaved caspase-3 western
blot, additional testing such as protein sequencing would be required. Unfortunately, that
is beyond the time restraints and scope o f this study. Therefore, in conclusion, the PCNA
western blots demonstrated that the PC10 clone, PCNA antibody is PCNA specific and
can be employed as a useful molecular tool for investigating proliferation in carcinogenic
and toxicologic studies with G. affinis. While the western blot analysis of G. affinis p53
and cleaved caspase-3 and PARP proteins revealed inconclusive results for use of
antibodies against these proteins as molecular tools, cell death can be detected using
another, more expensive alternative. This is the TUNEL method of labeling DNA strand
breaks discussed in the literature review.
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CHAPTER IV

DETECTION OF CELLULAR PROLIFERATION AND DEATH IN G. AFFINIS
EXPOSED TO 2-AMINOFLUORENE AND BENZIDINE
Purpose of Investigation

The objective o f this study is to examine the early carcinogenic effects o f the
PAAs, 2-AF and BZ both individually and combined on the ratio of cellular proliferation
and cell death in G. affinis livers at three time intervals. To accomplish this task, PCNA
antibodies and the TUNEL technique were used for immunohistochemical (IHC)
detection of proliferating cells and labeling of DNA strand breaks to identify cell death,
respectively. Both o f these techniques are well established as molecular tools in a
number of published studies discussed earlier in their literature reviews.
The use of a small fish species as the animal model reflects the ongoing research
involved in promoting aquatic species, G. affinis in particular, as sentinel species for
environmental carcinogenic and toxicology studies [27, 29, 34, 373,423], An extensive
literature search revealed the only carcinogen class tested on G. affinis is the alkylating
carcinogen, methylazoxymethano 1acetate (MAM-Ac) [27]. Therefore, PAAs were
selected as a different metabolic class of environmental carcinogens. Additionally, the
combination of 2-AF and BZ exposure to G. affinis is examined to determine any
variation from their individual effects. The exposure of two different chemicals
administered simultaneously can have an additive effect, a synergistic effect, or an
antagonistic effect [424-427]. The selection of liver tissue was based on its metabolism
of these PAAs as discussed previously in their literature reviews and on its rapid
development of neoplasms when exposed to carcinogens [27, 373].
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The three time intervals, 4, 8 and 12 weeks were chosen to represent the early
stages o f carcinogenesis in G. affinis. This was based on an earlier study of
hepatocarcinogenesis in G. affinis where the formation of tumors was reported in 33% of
the fish examined at 25 weeks [27]. Liver carcinomas have been reported as early as 6
weeks to 3 months in medaka [428, 429], The early stages are important as they reflect
the cellular events occurring at the onset of neoplastic formation.
Here we will examine cell proliferation and death in serial liver sections to
determine any early changes from their normal proliferative/death status due carcinogen
exposure. While the proliferation index and TUNEL index will be considered in the
analysis, the difference between cell proliferation and cell death will also be used. This
difference will control for the uncommon occurrence of cells staining positive for both
proliferation and death. As discussed in the literature review this may occur when cells
are undergoing extensive DNA repair. Therefore, the difference between the two assays
will give a more accurate picture o f cellular proliferation by controlling for false positives
and subtracting out the dying cells will reveal the net proliferation.

Experimental Design

To test the carcinogenic effects o f 2-AF and BZ on G. affinis livers, 21-22 fish are
randomly selected for each of 8 treatment groups and placed in 8 different 10-gallon
aquariums. Care and housing of G. affinis is maintained as discussed in Chapter 111. Fish
are acclimated for 2 weeks, then exposed to a high dose, 6.9 mM, or low dose, 0.069
mM, o f 2-AF and BZ individually or combined each day as outlined in Table 1. These
doses are based on carcinogenic studies in previous aquatic research [199, 310,430,431].
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There are two control groups, a non-treated control and a vehicle control. The control
group that does not have any treatment added to their food will have their food processed
in the same manner as the treated food. The vehicle control group’s food is treated with
ethanol (EtOH) the same as the treated groups since ethanol is a vehicle for solubolizing
and delivering 2-AF and BZ to their food.

Table 1
Experimental Design

Treatment Groups

# of Replicates

Time Intervals

No Treatment Control (N)

7

4 Weeks

8 Weeks

12 Weeks

Ethanol Vehicle Control (E)

7

4 Weeks

8 Weeks

12 Weeks

0.069 mM 2-Aminofluorene (AL)

7

4 Weeks

8 Weeks

12 Weeks

6.9 mM 2-Aminofluorene (AH)

7

4 Weeks

8 Weeks

12 Weeks

0.069 mM Benzidine (BL)

7

4 Weeks

8 Weeks

12 Weeks

6.9 mM Benzidine (BH)

7

4 Weeks

8 Weeks

12 Weeks

0.069 mM 2-Aminofluorene
and Benzidine (ABL)

7

4 Weeks

8 Weeks

12 Weeks

6.9 mM 2-Aminofluorene
and Benzidine (ABH)

7

4 Weeks

8 Weeks

12 Weeks

Both individually and combined, 2-AF and BZ is measured and the appropriate
amounts are solubolized in 150 ml ethanol and thoroughly mixed into their food
overnight on a roller mixer. The EtOH is evaporated from the treated food in a vacuum
for 48 hrs. Fish are fed the treated and control doses at approximately 1% o f their
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averaged body weight 2 times daily for 4, 8 and 12-week time intervals. As treatments
are completed, fish are randomly selected for sacrifice, liver removal and fixation, tissue
sectioning and PCNA, TUNEL and H&E staining.

Methods and Materials

Fish and Housing

Fish were housed and maintained as described in the same section in Chapter III.
Fish were dosed orally in their food in doses set forth in Table 1 using automatic fish
feeders. After treatment for 4 weeks 1/3 of the fish from each tank were randomly
selected, sacrificed and their livers removed and processed for IHC detection ofPCNA,
TUNEL labeling ofDNA strand breaks and subsequent H & E staining (this is discussed
in Chapter Y). After 8 weeks o f treatment, half o f the remaining fish in the aquariums
were randomly selected and processed in the same manner. The rest of the fish
completed their treatment at 12 weeks and were also processed as described.
Upon completion of a treatment interval, G. affinis were randomly selected from
each of the treatment groups and control tanks. The fish were anesthetized by
immediately placing them on ice for 45 min followed by decapitation and immediate
liver removal. Due the small size of the fish, the livers were removed under a dissection
microscope using microsurgical tools. Once the fish livers were carefully removed, they
were immediately placed in a fixative overnight for subsequent paraffin embedding and
tissue sectioning.
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Tissue Sectioning of Livers

Livers were fixed in 10% neutral buffered formalin (Sigma Aldrich, St. Louis,
MO) for 24 hrs, and then placed in cassettes for tissue processing for paraffin embedding.
Tissue was processed in a Fisher model 266MP Histomatic tissue processor (Fisher
Scientific, Pittsburgh, PA). Processed tissues were embedded in paraffin using the Fisher
HistoCenter™ (Fisher Scientific, Pittsburgh, PA). The paraffin embedded blocks were
placed on a surface maintained at approximately 4 °C for sectioning. Serial tissue
sections were cut using a microtome, model 1512 (Ernst Leitz Wetzlar GMBH,
Germany), 5 microns thin and adhered to poly-L-lysine poly prep slides (Sigma Aldrich,
St. Louis, MO) and incubated at 37 °C overnight.

PCNA Antibody and TUNEL Labeling o f Tissue Sections

As discussed in their appropriate literature reviews, PCNA antibodies and
TUNEL are used as biomarkers to identify proliferating cells and cell death, respectively.
Both of their protocols were optimized using positive and negative controls. These
controls were also used as internal controls. The positive control used for PCNA
detection was G. affinis intestinal tissue and the negative controls omitted exposure to the
primary PCNA antibody. The positive control used for TUNEL was rat mammary gland
tissue 3-5 days after weaning (Serologicals Corp., Norcross, GA) and negative controls
omitted exposure to the TdT enzyme. These controls were also used as internal controls.
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PCNA Antibody Labeling o f Tissue Sections

The protocol used for detection ofPCNA in G. affinis was based on a previously
published protocol that had been optimized for PCNA detection in three small fish
species including G. affinis [373]. Tissue section slides were placed in glass slide racks
(20 slides/rack) and immersed in the appropriate reagents in staining jars. Slides were
deparaffinized in xylenes, 2 X for 3 mins each, then hydrated in 100% EtOH, 2 X 1 min
each, 95% EtOH, 2 X 1 min each and rinsed in phosphate buffered saline with 5% Tween
20 (PBS-T) for 5 min. Slides were microwaved in 3% H 2O2 with 0.1% sodium azide for
2 min, rested 1 min and microwaved again for 30 sec for antigen retrieval. After cooling
for 15 min, slides were rinsed in 2 X for 5 min each in ddUH^O followed by 5 min in PBST. Slides were incubated in 0.5% powdered milk for 20 min for protein blocking.
Individual tissue sections were incubated in non-diluted PCNA antibody, PC10 clone
(Dako, Carpinteria, CA) for 1 hr and rinsed in PBS-T for 5 min. Mouse biotinylated
secondary antibody from the mouse super-sensitive detection kit (BioGenex Laboratories,
San Ramon, CA) was applied to the tissue sections for 30 min and rinsed in PBS-T for 5
min. Peroxidase-conjugated streptavidin (BioGenex Laboratories, San Ramon, CA) was
applied for 30 min and rinsed in PBS-T for 5 min. Diaminobenzidine (DAB) solution
was prepared by dissolving 1 mg DAB (Sigma Aldrich, St. Louis, MO) in 2 ml PBS-T.
Just before applying, 0.6 ul of 30% H2O2 was added. DAB solution was applied for 10
min then rinsed for 2 min in running tap water. Slides were counterstained with Mayer’s
modified hemotoxylin (Newcomer Supply, Middleton, WI) for 1 min, rinsed in running
tap water for 2 min and blued in PBS-T with 0.5% ammonium acetate (Sigma Aldrich,
St. Louis, MO) for 1 min. Slides were then dehydrated in 95% EtOH, 2 x 1 min each,

84

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

100% EtOH, 2 X 1 min each, and xylenes, 2 X 3 min each. Coverslips were adhered to
slides with Cytoseal mounting media (VWR Scientific, South Plainfield, NJ).

TUNEL Labeling o f Tissue Sections

TUNEL labeling o f the liver sections was carried out in accordance with the
protocol from the ApopTag® Apoptosis Detection Kit (Serologicals Corp, Norcross,
GA). Slight modifications to the protocol were as follows. DAB dissolved in PBS-T was
used as the peroxidase substrate and was applied for 10 min. Mayer’s modified
hemotoxylin was used as the counterstain, rinsed in running tap water for 2 min, and then
blued in blued in PBS-T with 0.5% ammonium acetate. Dehydration included immersing
in 75% EtOH for 1 min, 95% EtOH for 1 min and 100% EtOH for 2 min before
immersing in xylenes. Coverslips were adhered to the slides using Cytoseal XYL
mounting media (VWR Scientific, South Plainfield, NJ).

Determination of PI Index and TUNEL Index

PCNA and TUNEL slides o f liver tissue sections were observed under a
microscope containing a 19 mm eyepiece graticle with a 1mm grid with 10 vertical and
horizontal lines (Electron Microscopy Sciences, Ft. Washington, PA). This grid was used
for tracking and counting cells. When a focal area of positive cells was observed they
were included in the count on the grid, however, the majority o f normal (non-positive)
cells were also within in the grid. If more than one focal area o f positive cells were
encountered, only those that fell within the 1mm grid were counted. The grid was not
moved around to include all areas with positive foci, only those within the original setting
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of the grid were included in the count. This was to give a representative count of the
overall tissue. Counting ofPCNA labeled cells is reported in scientific literature as a
PCNA index (PI), the number ofPCNA positive cells per 1000 cells, and that index is
used here for reporting the number of proliferating cells in each tissue section [181-183].
This index was also used for reporting the number of TUNEL positive cells in each tissue
section. All positive cells were counted including those lightly stained as established in
the guidelines of the Registry o f Industrial Toxicology Animal-data Cell Proliferation and
Apoptosis (RITA CEPA) group. The RITA CEPA group consists of 16 European
companies and organizations whose primary goal is assisting its members in proliferation
studies for comparison and interpretation of results in accordance with self-established
standardized protocols for the subsequent formation of a cell proliferation and apoptosis
database. PCNA and TUNEL positive cell counts were spot checked by an electron
microscopist from the Biological Imaging Center at Western Michigan University.
Due to the death of four fish during the experiment and three paraffin blocks that
would not yield good sections, their individual PI and TI counts were derived from the
averages in their particular treatment group since they accounted for <5% of the samples.
This was done in order to maintain sample numbers that were balanced for statistical
analysis with minimal manipulation and to avoid discarding of pertinent data collected.
This averaging was double-checked to ensure it did not change the original values of the
means from the actual data collected.
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Results

The means and standard deviations of PI, TI and their difference are reported in
Table 2 and a histogram of their individual means and standard error are located in
Figures 15 - 23. It is important to note that the y-axis of these histograms are not uniform
and change between the individual histograms. The histograms reflect significant
increases in some o f the treatment groups when compared to the others. However, these
increases may be due to the contribution o f outliers rather than effects from the PAA,
since the standard error for those groups is typically higher than the remaining groups.
Also, both 2AF and BZ are from the same metabolic class, resulting in like metabolic
products, and there are no reports in literature that they enhance or decrease the effects of
one another.

PCNA Index

PCNA staining appeared restricted to the nuclei and varied in the intensity of
staining as seen in Figure 24. PCNA positivity was widely distributed in some tissue
sections, focally located in other tissue sections or a combination of the two. The number
ofPCNA positive cells varied greatly between and within dose groups. The variation
between dose groups is observed in the means reported in Table 2. The PI contained
several expected outliers as seen in the boxplot o f Wilcoxon studentized residuals in
Figure 25. PI data did not have a normal distribution as revealed by the lack o f linearity
in the Q-Q plot o f studentized residuals in Figure 26. The desire for inclusion o f outliers
and the lack o f a normal distribution dictated a robust non-parametric statistical analysis
of the data. Therefore, Wilcoxon’s robust 2-way analysis for time and treatment effects
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and interaction was performed on the data and reported in Table 3. Effects o f the three
time intervals, 4, 8, and 12 weeks had a p-value o f 3.14e-05, treatments had a p-value of
0, and the interaction between times and treatments had a p-value of 3.42e-05. Both of
the effects and their interaction revealed high statistical significance.
Further statistical analysis was conducted on the differences between controls and
treatments by using Fisher’s paired least significant differences test. Statistically
significant differences in contrasts are reported in Table 4. Significant contrasts were
observed between 4 wks and 12 wks, and 8 wks and 12 wks. There were not any
significant differences between the no treatment control and the EtOH vehicle control.
All treatments, except the low dose (0.069mM) of 2AF, had significant contrasts with the
EtOH vehicle control. Contrasts were noted between the low 2AF dose and the
remaining treatment groups indicating a no-effects level for the low dose 2AF exposure
with regard to cellular proliferation. The high dose of 2AF and the high dose 2AF/BZ
had significant contrasts, while the low dose of BZ significantly contrasted with the high
doses of BZ and 2AF/BZ. The 2AF/BZ high and low doses also had significant contrasts
with one another. These differences between treatment groups reflect the increased
proliferative effects, of 2AF/BZ and BZ at the low dose and 2AF at the high dose, above
the already significant proliferative effects of 2AF/BZ and BZ at the high dose.
Because there is so little data available on PCNA staining o f fish livers and the data that
exists is not standardized, a direct comparison with other results is not feasible. For
example, one study with F, grandis, calculates the PI as PCNA positive cells/mm2 of
tissue [199]. Due to variation in the number of cells per mm2 in the G. qffinis livers, this
method for calculating the PI would have resulted in a collection o f non-standardized
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data. The most standardized of methods for counting PCNA positive cells in literature is
to count the number ofPCNA positive cells/1000 cells.

TUNEL Index

TUNEL staining, shown in Figure 27, was localized in the nuclei and stained at
varying intensities. TUNEL positive cells were widely distributed in most tissue sections
with rare focal occurrence. Over 75% (127/168) of the tissue sections examined
exhibited a low TI, 0 - 3 , while 20% (32/168) exhibited TIs from 4-12 and only 5%
(9/168) had 74> TIs >12. These counts resulted in extremely discrete data. The upper
5% of the TI values resulted in outliers as plotted in the boxplot of Wilcoxon studentized
residuals in Figure 28. This data did not have a normal distribution as indicated in the
non-linear Q-Q plot o f studentized residuals in Figure 29. For inclusion of outliers and
the lack of normal distribution the non-parametric robust Wilcoxon 2-way analysis for
time and treatment effects and interaction was used in the statistical analysis. However,
this was problematic since the data was extremely discrete. The discrete data prohibited
the robust Wilcoxon 2-way analysis from formulating a true statistical analysis as
evidenced by the negative F-statistic as reported in Table 5. To overcome this difficulty,
a value between -0.05 and 0.05 was randomly added to the actual TI values to create a
little ‘noise’. To ensure that this manipulation o f the data did not significantly change the
true value o f the data a comparison o f the raw data and the adjusted data, using a least
squares method o f 2-way anlaysis, was employed. The results are reported in Table 5 of
the raw data and Table 6 o f the adjusted data. With the raw data, the least squares pvalue is 0.0586 and F-statistic is 2.89 for time effects, p-value is 0.399 and F-statistic is
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Table 2
Means for TUNEL Index, PCNA Index and Their Differences

Treatment
Groups

Time
Intervals
TUNEL
(Weeks) Means Std. Dev.

PCNA
Means Std. Dev.

PCNA- TUNEL
Means Std. Dev

Control

4
8
12

1.857
4.14
2.0

2.035
5.669
1.414

1.571
4.71
18.14

2.299
6.422
13.619

-0.286
0.57
16.14

1.7
9.2
12.72

EtOH Vehicle
Control

4
8
12

0.857
4.57
2.429

0.9
4.509
0.787

5.29
13.71
7.86

6.751
13.13
5.87

4.43
9.14
5.43

1.64
11.47
5.44

0.069 mM 2AF

4
8
12

15.29 26.291
3.0
2.517
1.286 2.563

14.29
16.57
33.3

23.436
12.581
38.9

-1.0
13.57
32.0

11.78
11.82
39.32

6.9 mM 2AF

4
8
12

3.29
2.0
1.286

3.352
1.826
1.113

23.9
16.14
67.9

35.145
5.27
47.90

20.6
14.14
66.6

35.52
6.07
48.77

0.069 xnMBZ

4
8
12

6.43
6.241
3.714 1.113
2.429 10.565

89.1
13.29
31.4

66.76
12.958
28.919

82.7
9.57
29.0

69.51
12.55
30.05

6.9 mM BZ

4
8
12

6.86 15.115
2.143 1.773
1.571 1.618

26.71
19.43
34.3

21.631
15.619
27.14

19.9
17.29
32.7

30.1
17.0
27.65

0.069 mM 2AF/BZ

4
8
12

3.14
1.571
3.0

1.069
1.813
1.512

21.86
46.0
37.14

19.557
44.52
18.3

18.71
44.4
34.14

20.31
45.57
18.35

6.9 mM 2AF/BZ

4
8
12

2.0
1.714
1.714

2.449
1.799
1.604

15.57
15.14
38.1

7.39
12.967
28.644

13.57
13.43
36.4

7.23
14.06
28.66
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Figure 15.

Histogram o f PCNA Index Means and Standard Deviations of Treatment
and Control Groups at 4 Weeks.
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Figure 16.

Histogram ofPCNA Index Means and Standard Deviations of Treatment
and Control Groups at 8 Weeks.
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Figure 17.

Histogram o f PCNA Index Means and Standard Deviations of Treatment
and Control Groups at 12 Weeks.
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Figure 18.

Histogram o f TUNEL Index Means and Standard Deviations o f Treatment
and Control Groups at 4 Weeks.
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Histogram o f TUNEL Index Means and Standard Deviations of Treatment
and Control Groups at 8 Weeks.
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Figure 20.

Histogram o f TUNEL Index Means and Standard Deviations o f Treatment
and Control Groups at 12 Weeks,
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Figure 21.

Histogram o f PI - TI Index Means and Standard Deviations of Treatment
and Control Groups at 4 Weeks,
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Histogram o f PI - TI Index Means and Standard Deviations of Treatment
and Control Groups at 8 Weeks.
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Figure 23.

Histogram o f PI - H Index Means and Standard Deviations ofTreatment
and Control Groups at 12 Weeks.
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Figure 24.

PCNA Positives from a G. qffinis Liver Tissue Section.

Figure 25.

PCNA Boxplot of Wilcoxon Studentized Residuals.
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THEORETICAL QUANTDUES

Figure 26.

PCNA Q-Q Plot o f Studentized Residuals.

Table 3
PCNA - Tests o f Time and Treatment Effects and Interaction

Wilcoxon Robust

Effects and
Interaction

F-Statistic

Time Intervals

11.1528

df

p-value

2,144

3.14116e-Q5

Treatments

8.38557

7,144

0

Time Intervals/Treatment

3.64758

14,144

3.42727e-G5
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Table 4
PCNA - Fisher’s Paired Least Significant Differences With Statistical Significance

Wilcoxon Robust Contrasts*

Contrast

Estimate

Error Term

4 Wks vs 12 Wks

-10.8884

5.50334

(-16.3917, -5,38507)

8 Wks vs 12 Wks

-13.7978

5.50334

(-19.3012, -8.29451)

8.98691

(-18.0719, -0.0980654)

No Treatment vs 2AF Low Dose

-9.08497

Interval

No Treatment vs 2AF High Dose

-22.6851

8.98691

(-31.672,-13.6982)

No Treatment vs BZ Low Dose

-25.9979

8.98691

(-34.9848,-17.011)

No Treatment vs BZ High Dose

-15.5676

8.98691

(-24.5545, -6.58072)

No Treatment vs 2AF/BZ Low
Dose

-23.1327

8.98691

(-32.1196,-14.1458)

No Treatment vs 2AF/BZ High
Dose

-13.6326

8.98691

(-22.6195, -4.64572)

Ethanol Control vs 2AF High Dose -22.0184

8.98691

(-31,0053,-13.0315)

Ethanol Control vs BZ Low Dose

-25.3312

8.98691

(-34.3181,-16.3443)

Ethanol Control vs BZ High Dose

-14.901

8.98691

(-23.8879, -5.91406)

Ethanol Control vs 2AF/BZ Low
Dose

-22.4661

8.98691

(-31.453,-13.4792)

Ethanol Control vs 2AF/BZ High
Dose

-12.966

8.98691

(-21.9529, -3.97906)

2AF Low Dose vs 2AF High Dose

-13.6001

8.98691

(-22.587, -4.61321)

2AF Low Dose vs BZ Low Dose

-16.9129

8.98691

(-25.8998, -7.92601)

2AF Low Dose vs 2AF/BZ Low

-14.0478

8.98691

(-23.0347, -5.06084)
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Table 4 - Continued

Wilcoxon Robust Contrasts

Contrast

Estimate

Error Term

Interval

Dose
2AF High Dose vs 2AF/BZ High
Dose

9.05247

8.98691

(0.0655584, 18.0394)

BZ Low Dose vs BZ High Dose

10.4303

8.98691

(1.44335, 19.4172)

BZ Low Dose vs 2AF/BZ High
Dose

12.3653

8.98691

(3.37835,21.3522)

2AF/BZ Low Dose vs 2AF/BZ
High Dose

9.5011

8.98691

(0.51319, 18.487)

*95% Individual Confidence Intervals
1.05 for treatment effects and p-value is 0.226 and F-statistic is 1.28 for their interaction.
This least squares 2-way analysis was comparable to the adjusted data’s p-value of
0.0598 and F-statistic of 2.88 for time effects, p-value o f 0.397 and F-statistic of 1.05 for
treatment effects and p-value. Since there were no significant changes to the data, we
continued our analysis with the adjusted data.
Wilcoxon 2-way analysis o f the adjusted data in Table 6 shows statistical
significance for treatment effects with a p-value of 0.00556 and F-statistic of 3.01 and its
interaction with time (p-value is 0.0248 and F-statistic is 1.96), but not with the time
effects (p-value is 0.219 and F-statistic is 1.53). This indicates that treatments were
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Figure 27.

TUNEL Positives from a G. qffinis Liver Tissue Section.

O

Figure 28,

TUNEL Boxplot o f Wilcoxon Studentized Residuals.
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Figure 29.

TUNEL Q-Q Plot o f Studentized Residuals.

Table 5
TUNEL - Comparison o f Tests ofTime and Treatment Effects and Interactions

Wilcoxon Robust

Least Squares

Effects and
Interaction

F-Statistic

df

p-Value

F-Statistic

df

Time Intervals

-5.11573

2,144

1

2.89421

2,144

0.055688

Treatments

0.448136

7,144

0.87013

1.05021

7,144

0.398994

Time Intervals
/Treatment

0.589617

14,144

0.0869931

1.28157

14,144

0.225583
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p-Value

Table 6
TUNEL - Adjusted Comparison o f Tests Time and Treatment Effects and Interactions

Least Squares

Wilcoxon Robust

Effects and
Interaction

F-Statistic

Time Intervals

1.53316

Treatments

3.0108

Time Intervals
/Treatment

1.96045

df

p-Value

F-Statistic

df

p-Value

2,144

0.219355

2.87527

2,144

0.0596451

7,144

0.00555927

1.05284

7,144

0.397222

14,144

0.0248168

1.28226

14,144

0.225149

Table 7
TUNEL - Fisher’s Paired Least Significant Differences With Statistical Significance

Wilcoxon Robust Contrasts*

Contrast

Estimate

Error Term

Interval

No Treatment vs BZ Low Dose

-1.96798

0.759272

(-2.72726,-1.20871)

Ethanol Control vs BZ Low Dose

-1.32372

0.759272

(-2.08299, -0.56445)

2AF Low Dose vs BZ Low Dose

-1.66739

0.759272

(-2.42667, -0.90812)

2AF High Dose vs BZ Low Dose

-1.68261

0.759272

(-2.44188, -0.923338)

1.99555

0.759272

(1.23628, 2.75483)

BZ Low Dose vs BZ High Dose

BZ Low Dose vs 2AF/BZ Low Dose 1.67372

0.759272

(0.914451, 2.433)
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Table 7 - Continued

Wilcoxon Robust Contrasts

Contrast

Estimate

Error Term

Interval

BZ Low Dose vs 2AF/BZ High
High Dose

2.01209

0.759272

(1.25282, 2.77136)

*95% Individual Confidence Intervals
statistically significant as was their interaction with time, but that time alone did not have
a statistically significant effect on the number of TUNEL positive cells.
Further analysis was conducted for determining differences between time
intervals and between treatment groups. The results are reported in Table 7. Using
Fisher’s protected least square differences, no significant contrasts were observed
between time intervals. No significant contrasts were observed between the no treatment
control and EtOH vehicle control. Statistically significant contrasts were observed
between the EtOH vehicle control and low dose of BZ, but not with the remaining
treatment groups.

PCNA Index Minus TUNEL Index

The difference in cellular proliferation and death results in net cellular growth.
To determine whether cellular proliferation exceeds cellular death in carcinogenesis,
studies have examined the difference between PI and TI [432-434]. This difference is
imperative in carcinogenic investigations since a fine balance between positive and
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negative regulation o f cell growth is essential in normal development and growth,
whereas a disruption in this balance during carcinogenesis results in tumor formation
[435]. In this study the differences between cellular proliferation (PI) and cellular death
(TI) were examined and exhibited a combined mean of 5.9 for the control groups and
27.65 for the treated groups. These results are indicative o f positive cellular growth, with
treatment groups producing a 4.7 fold increase in cellular growth over the controls. A list
of the means for the individual control groups and treatment groups are located in
Table 2. Results from the differences between PI and TI contained expected outliers as
demonstrated in the boxplot o f Wilcoxon studentized residuals in Figure 30. This
indicates that the data did not have a normal distribution. Additionally, the Q-Q plot of
studentized residuals in Figure 31 indicates a lack of a linear response. Therefore, the
non-parametric robust Wilcoxon 2-way analysis o f time and treatment effects and
interaction was used for statistical analysis. Results from this analysis are listed in Table
8. Both time intervals and treatments along with their interaction were highly statistically
significant with p-values o f 3.16e-06, 0, and 2.85e-Q5 and F-statistics of 13.84, 8.67, and
3.69, respectively. Contrasts, listed in Table 9, indicate significant differences between 4
wks and 12 wks, and between 8 wks and 12 wks. No significant contrasts were noted
between the no treatment control and the EtOH vehicle control. Significant contrasts
existed between the EtOH vehicle control and all treatment groups except the 2AF low
dose. The greatest contrast between control and treatment was with the 2AF/BZ low
dose combination.
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Discussion

A hallmark of tumor formation is unregulated cell growth. This is evidenced in
numerous studies examining the proliferative rates of neoplastic tissue. Several PCNA
immunoreactivity studies have been conducted on human livers exhibiting chronic liver
diseases and hepatocellular carcinomas [193,195, 196, 199,434, 436-438]. Normal liver
tissue exhibited a minimal PCNA levels, while hepatocellular carcinomas (HCC)
exhibited increasing PCNA levels that correspond with Grade. For example, one study
indicated the PCNA levels in HCC Grades 1, 2, 3 and 4 were 12.2%, 17.5%, 53.7% and
83.9%, respectively [438]. In another study, normal liver tissue resulted in PCNA levels
o f 0.78%, while the HCC o f Edmondson’s type I, II and III revealed Pis of 4.83%, 6.65%
and 30.6%, respectively. This PI increase is also reported in progressive chronic liver
diseases, where PI increases were observed as the disease state progresses until the stage
of cirrhosis, where it decreased [437]. In the fish, Fundulus grandis, the potent
carcinogens 2AF and jV-methyl-Ap-nitro-iV-nitrosoguanidine (MNNG) were administered
and the PCNA levels were assayed. Exposed fish had statistically significant elevated
liver PCNA levels in both exposure groups (p = 0.003). Studies with rats exposed to
2AAF as an initiator, promoter, or both, demonstrate apoptotic cell death, regenerative
proliferation, morphological alterations and tumor formation [439-445]. This progression
has also been observed in azo-based dye exposures [439-441]. Although cellular
proliferation is a major facet in tumor development, it is also important to consider the
regulation o f cell growth and cell death. Reductions in the rate of cell death can result in
increased cellular growth rates in the absence o f proliferative changes [435].
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Since G. affinis is an excellent sentinel species for biomonitoring of
environmental carcinogens, we investigated the effects o f the arylamine metabolic class
of carcinogens on proliferation in their livers. The arylamines, 2AF and BZ have been
shown to form hepatic neoplastic lesions in several rodent models tested, including 2AF
in the fish model, Fundulus grandis [342, 343,446-452].
To examine the early cellular growth patterns preceding neoplastic formation
resulting from exposure to 2AF and/or BZ in G. affinis, both proliferation and death of
liver cells were assayed after 4, 8, and 12-week exposure intervals. The working
hypothesis is that an increase in cellular proliferation and/or a decrease in cellular death
would occur due to arylamine exposure in the early stages of their neoplastic
development as has been observed in rodents. Cell proliferation was assessed using
PCNA antibody reactivity, cell death using the TUNEL method, and cell growth by the
differences in PI and TI. Results o f the PCNA immunohistochemistry assay indicated
significant increases in proliferation that were associated with exposure intervals,
treatments and their interaction, Table 3. Although significant increases were observed in
the higher doses of BZ and 2AF/BZ, Table 4, increases were most pronounced for the
low doses of BZ and its combination 2AF/BZ, along with 2AF at the higher dose. The
proliferative effects of 2AF at 0.069mM (1 ppm) may be too gradual for statistical
significance, since the means increased substantially from the 4 and 8 wk points to 12
wks, Table 2. This was observed in rats treated with 50 ppm 2AAF where foci developed
much more gradually than at higher doses [442], With regard to TUNEL detection for
assaying cell death, treatments were statistically significant as was their interaction with
time, Table 6. The only increase with statistical significance was demonstrated for the
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PCNA and TUNEL Differences Boxplot of Wilcoxon Studentized
Residuals.

WILCOXSON STUDENTIZED RESIDUALS

Figure 30.

THEORETICAL QUANTILES

Figure 31.

PCNA and TUNEL Differences Q-Q Plot o f Studentized Residuals.
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Table 8
PCNA and TUNEL Differences - Test of Time and Treatment Effects and Interaction

Wilcoxon Robust

Effects and
Interaction

F-Statistic

Time Intervals

13.8364

df

p-value

2,144

3.15905e-06
0

Treatments

8.67168

7,144

Time Intervals/Treatment

3.6933

14,144

2.8491e-05

Table 9
PCNA and TUNEL Differences - Fisher’s Paired Least Significant
Differences With Statistical Significance

Wilcoxon Robust Contrasts*

Contrast

Estimate

Error Term

4 Wks vs 12 Wks

-12.8567

5.34615

(-18.2029, -7.51055)

8 Wks vs 12 Wks

-14.4132

5.34615

(-19.7594, -9.06706)

No Treatment vs 2AF High Dose

-22.965

8.73023

(-31.6952,-14.2347)

No Treatment vs BZ Low Dose

-22.3636

8.73023

(-31.0938,-13.6333)

No Treatment vs BZ High Dose

-16.3462

8.73023

(-25.0764, -7.61594)

No Treatment vs 2AF/BZ Low Dose -23.2858

8.73023

(-32.016, -14.5556)

Interval
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Table 9 - Continued

Wilcoxon Robust Contrasts

Contrast

Estimate

Error Term

Interval

No Treatment vs 2AF/BZ High
Dose

-13.9874

8.73023

(-22.7177, -5.25721)

Ethanol Control vs 2AF High Dose -22.3341

8.73023

(-31.0644,-13.6039)

Ethanol Control vs BZ Low Dose

-21.7327

8.73023

(-30.463, -13.0025)

Ethanol Control vs BZ High Dose

-15.7154

8.73023

(-24.4456, -6.98513)

Ethanol Control vs 2AF/BZ Low
Dose

-22.655

8.73023

(-31.3852,-13.9248)

Ethanol Control vs 2AJP/BZ High
Dose

-13.3566

8.73023

(-22.0869, -4.6264)

2AF Low Dose vs 2AF High Dose

-16.7878

8.73023

(-25.518, -8.05758)

2AF Low Dose vs BZ Low Dose

-16.1864

8.73023

(-24.9166, -7.45619)

2AF Low Dose vs BZ High Dose

-10.169

8.73023

(-18.8993,-1.4388)

2AF Low Dose vs 2AF/BZ Low
Dose

-17.1087

8.73023

(-25.8389, -8.37843)

2AF High Dose vs 2AF/BZ High
Dose

8.97751

8.73023

(0.247284, 17.7077)

2AF/BZ Low Dose vs 2AF/BZ
High Dose

9.29836

8.73023

(0.568134, 18.0286)

*95% Individual Confidence Intervals
low dose BZ exposure over the 4, 8 and 12 wk exposures when contrasted with the
controls. The controls were not significantly different from one another in all assays.
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This early transient increase in cell death was also observed in the rodent studies. This
early cell death and subsequent increase in proliferation is the subject of several studies
into the early proliferative effects of 2AAF in rats [442,444, 453-456]. Evidence is
accumulating that 2AAF induces a stress response where apoptosis is triggered by altered
mitochondrial permeability transition effects and a compensatory regenerative
proliferation follows as part o f an adaptive response [442]. One o f the most sensitive
parameters for this adaptive response was the inhibition o f mitochondrial permeability
transition pores that are involved in inducing apoptosis. They exhibited 40% to 100 %
inhibition by 8 wks in a dose-dependent manner [442, 457],
To determine whether the cellular proliferation exceeds cell death, the differences
between the PI and TI were examined. The difference between PI and TI revealed the
low dose of 2AF/BZ as the most statistically significant, while the high dose of 2AF and
low dose of BZ followed in significance, Table 9. This indicates the net cellular growth
o f the arylamine exposed groups is positive and increased when compared to controls.
This aligns with the increased proliferative state and decreased apoptosis in livers of
rodents when exposed to 2AAF [442, 444,453,454]. Although the differences in PI and
TI were closely aligned, the order of significance for contrasts changed, Tables 4 and 9.
These results indicate that when examining cell proliferation alone or cell death alone, the
results can be somewhat misleading with regard to net cellular growth. Studies
examining tumor growth and apoptosis suggest that failure to consider apoptosis in cell
growth may account for the discrepancies between the actual and expected growth of
tumors calculated from cell proliferation rates [435, 458]. Thus, when taking into
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account the balance of proliferating cells and dying cells, whether apoptotic or necrotic, a
more precise measurement of cellular growth is achieved.
With that considered, this study demonstrates the statistical significance o f the
polycyclic arylamines, 2AF and BZ and their combination in overall cellular growth in G.
affinis livers. Effects from their exposure indicate increased net cellular proliferation in
all exposures except the low dose of 2AF. When cells are dividing the potential for
neoplastic formation also increases. This was demonstrated in rat hepatocytes and human
fibroblasts where clastogenesis was shown to be cell cycle dependent and maximally
susceptible when cells were at the Gl/S border [160]. The studies conducted on rats
revealed an early increase in cell death (2 weeks) followed by a delayed increase in cell
proliferation (4 weeks) and subsequent tumor formation with exposure to 50,100,200,
400, and 800 ppm 2AAF [442,453]. G. affinis exposed to 2AF and BZ revealed an early
increase in cell death at 4 weeks than diminishes at 8 and 12 weeks with increased
proliferation at 4 weeks that is significantly increased by 12 weeks. The results from this
investigation with both 2AF and BZ at 0.069mM (1 ppm) and 6.9mM (100 ppm) are
aligned with results from the rat studies and Fundulus grandis study. The 2AF study on
the fish Fundulus grandis reported significant differences in PCNA index, and
PCNA/TUNEL ratio with slight increases but not statistically significant differences in
TUNEL index during exposure to 6.9mM (100 ppm) 2AF [199].
The results from this study additionally indicate the utility ofPCNA and TUNEL
immunohistochemistry for the detection of net cellular proliferation due to exposure of
environmental carcinogens in field studies using sentinel species such as G. affinis. So
far, the two metabolic classes o f environmental carcinogens that have been tested on G.
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affinis result in increased proliferation that can be detected and differentiated from non
exposed groups [27, 199].
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CHAPTER V

HISTOPATHOLOGY OF 2-AMINOFLUORENE AND BENZIDINE TREATED G.
AFFINIS LIVERS
Purpose o f Study

The objective o f histological studies in G. affinis liver tissue sections is to
determine any gross morphological differences between treatment groups and controls
during the 4, 8 and 12-week time intervals. The major morphological features examined
here are preneoplastic proliferative states, formation o f foci and neoplastic formations.
These features are important in carcinogenic studies, as they represent the fundamental
changes that occur in tissues when exposed to environmental carcinogens. Histological
studies of azo-based dyes and 2AAF exposure in rodents have reported proliferation of
oval cells in livers with in the early stages o f chemically induced carcinogenesis and
subsequent tumor formations that are related to this altered state [440,447,459-462]. In
this study, a well-established protocol of hematoxylin and eosin (H&E) staining are used
to discriminate normal and morphologically altered foci.

Experimental Design

The experimental design is basically identical to the experimental design in
Chapter IV with regard to preparation, dosing and administration of 2AF and BZ, and
processing o f G. affinis livers. Slides o f the liver tissue sections are stained with H&E
and examined under a microscope at 40 X for morphological aberrations. The tissue
sections are stained with hematoxylin for nucleic acids and eosin for protein. H&E
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staining has been used extensively in studies to identify morphological features such as
apoptosis, infections, chromatin texture and malignant melanomas just to name a few
[463-467]. The morphological features of previous cytological studies on the liver of G,
affinis are used as guidelines in the histological analysis [27, 380, 468]. Diagnoses of
altered cellular foci and tumor formation are verified by an ACVP certified pathologist
experienced in G. affinis liver histology.
Additionally, two groups of the PCNA stained slides, the EtOH vehicle controls
and the 4 week BZ low dose, were re-examined using DIC microscopy to determine the
morphological characteristics of the PCNA positive foci. This was to verify whether the
foci observed in the PCNA positive focal regions had the same morphological
characteristics as those observed in the H&E stained sections.

Methods and Materials

The fish were maintained and housed as stated in Chapter III. Processing of fish
and their livers for preparation of serial tissue sections are described in Chapter IV in its
corresponding sections.
Tissue section slides were placed in glass slide racks (20 slides/rack) and
immersed in the appropriate reagents in staining jars for H&E staining. Slides were
deparaffinized in xylenes, 2 X for 3 mins each, then hydrated in 100% EtOH, 15 dips,
95% EtOH, 15 dips and 70% EtOH, 10 dips, then rinsed for 3 min in running tap water.
Slides were stained with Mayer’s modified hemotoxylin (Newcomer Supply, Middleton,
WI) for 5 min, rinsed in running tap water for 2 min and blued in PBS-T with 0.5%
ammonium acetate (Sigma Aldrich, St, Louis, MO) for 1 min. Sections were
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counterstained with eosin (Sigma Aldrich, St. Louis, MO) for 3 min and rinsed in running
tap water for 2 min. Slides were then dehydrated in 70% EtOH, 3 dips, 95% EtOH, 5
dips, 100% EtOH, 2 X 3 min each, and xylenes, 2 X 3 min each. Coverslips were
adhered to slides with Cytoseal XYL mounting media (VWR Scientific, South Plainfield,
NJ).

Results

Livers o f G. affinis and other teleost fish are not lobular in architecture. Instead
their liver architecture is an arrangement of tubules o f hepatocytes in which the tubules
are composed of 5-7 hepatocytes in a concentric arrangement [469]. Histopathological
examination of H&E stained G. affinis liver tissue in both the controls and treated groups
exhibited varying degrees o f vacuoiation, Vacuolation was much more prominent in the
PAA exposed groups, than in the controls. They typically appeared as clear
intracytoplasmic vacuoles and were distributed throughout the section. Pigmented
macrophage aggregates (PMA) were observed in both the controls and treated groups, but
were more frequently observed in the treated groups. Granulomas were identified in
bothcontrols and treated groups, however they were rare by comparison in the controls.
Although difficult to differentiate at times, granulomas contained densely packed
pigmented macrophages encapsulated by small basophilic nuclei in epithelial appearing
cells. An example o f PMA and granuloma can be seen in Figure 32, the upper arrow
points to spindle cell proliferation, the middle arrow to a granuloma and the lower arrow
to a PMA. Both PMA and granulomas are inflammatory lesions and may be due to
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Table 10

Histopathological Examination of G. affinis Lives After Exposure to 2AF and BZ

Treatment Group

No Treatment Control

EtOH Vehicle Control

0.069 mM 2AF

6.9 mM 2AF

0.069 mMBZ

6.9 mMBZ

0.069 mM 2AF/BZ

6.9 mM 2AF/BZ

Time (Wks)

Oval to Spindle Shaped
Cell Altered Foci

Spindle Cell
Tumors

4
8
12

0/6
1/7
1/6

4
8

0/7
1/6

_

12

1/7

-

4
8
12

3/6
3/6
2/6

-

4
8
12

1/5
3/7
3/6

4
8
12

2/7
2/7
3/7

4
8
12

1/7
1/7
3/7

4
8
12

0/6
2/7
3/6

4
8
12

4/7
2/7
2/6
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an undiagnosed infection or due to phagocytosis of cellular debris resulting from necrosis
or apoptosis. No indication of parasitic invasion was observed, however, microbial
infection and phagocytosis of cellular debris cannot be ruled out.
The appearance of altered cellular foci occurred predominately in the treated
groups, although 2 cases were observed in each o f the control groups. Table 10 lists the
number of the oval to spindled shaped basophilic duct-like cells comprising the altered
foci and tumor observed in the treated groups of G. affinis. The areas of altered foci were
small, basophilic clusters o f oval to spindle shaped cells typically located by nearby
vessels and without compression o f surrounding tissue. These basophilic foci o f spindle
cell proliferation are shown in Figures 32 and 33, bottom arrow and only arrow,
respectively. These cells had enlarged nuclear to cytoplasmic ratios and were deeply
basophilic in comparison with adjacent parenchyma. These foci differed from the
appearance o f the parenchyma and bile duct cells o f the control livers. The normal
parenchyma, hepatocytes, were much larger cells with smaller nuclear to cytoplasmic
ratios. The normal bile duct cells were arranged as a single row of small basophilic cells
in a circular or tubular fashion, whereas the cells contained in the basophilic foci, were
not uniformly distributed as a single layer o f concentric cells. Instead, they appeared as
varying numbers o f cells in close proximity to one another without a duct-like structure.
To determine whether these were also the cells observed in the PCNA positive focal
regions of the PCNA stained sections, two representative groups, the 4 week EtOH
vehicle control and BZ low dose group, ofPCNA stained sections were observed using
DIC microscopy. The PCNA positive focal regions were selected on these sections, there
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morphology was examined. The morphology of the PCNA positive focal sites in the
treated groups revealed a higher nuclear to cytoplasmic ratio with oval to spindle shaped
cells that were smaller and more condensed than the surrounding parenchyma. This
indicates that these oval to spindle shaped cells in the basophilic foci were proliferating in
the foci examined. The ratio of PCNA positive cells to total cells counted in two focal
sites for the 4 weeks EtOH vehicle controls totaled 13 PCNA positive cells/75 cells total
and their morphology had lower nuclear to cytoplasmic ratios. This same value for the 4
week BZ low dose was 83 PCNA positive cells/657 cells total in 12 focal sites. Previous
exposure studies have indicated the occurrence of these small basophilic foci in fish after
exposure to MAM-Ac, diethylnitrosamine (DEN), or creosote [27, 365, 470]. These
areas ofbasophilic altered cellular foci occurred in 0%, 15% and 15% of controls and
29%, 32% and 42% of treated fish at 4, 8 and 12 weeks, respectively. By treatment
group, these foci appeared in 42% of 2AF groups, 29% of BZ groups and 33% of
2AF/BZ groups. Only one tumor was observed and this was a spindle cell tumor in the
0.069 mM BZ group at 8 weeks.

Discussion

The results from histological examination o f G. affinis livers after exposure to
2AF, BZ and their combination at low and high doses are similar to those studies o f azobased dyes and 2AAF exposure in rats, mice and fish [27, 440, 450, 453, 471,472].
Those studies have all indicated an increase in oval cell (bile duct) proliferation after
exposure and subsequent formation o f tumors. In this study, 10% of the control groups
exhibited basophilic oval/spindle cell proliferation. That was substantially
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Figure 32.

Altered Foci, Granuloma and PMA, respectively, in G. affinis Liver.

■■M ill
Figure 33.

Basophilic Foci of Spindle Cell Proliferation in G. affinis Liver.
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increased in the treated groups anywhere from a 2.9 to 4.2 fold over the controls. The
2AF exposure groups had the greatest incidence of basophilic altered cellular foci,
occurring in 42% of the 2AF hepatic tissue examined, followed by 33% of 2AF/BZ and
29% o f the BZ. Although these were early studies, a spindle tumor was observed in an 8
week 0.069 mM BZ exposed liver.
A great deal of experimentation has taken place with livers and hepatocytes in
determining if these areas of altered cellular foci comprised of bile duct like oval cells are
the preneoplastic origin o f subsequent neoplasms that are consistently observed during
exposures to azo-based dyes and 2AAF [27, 440,450, 453, 456, 471-474]. A large array
of antibodies to hepatocytes, oval cells/bile duct, shared-hepatocytes and bile ducts, and
neoplastic antigens in F-344 rats were assayed in primary hepatocellular carcinomas
induced by exposure to a single dose of A-nitrosodiethylamine (DENA) followed by 14
days of 2.5 mg 2AAF exposure. Their results indicated that the antigenic phenotype
expressed in 20% of the primary hepatocellular carcinomas (PHC) contained both oval
cell- and hepatocyte-associated antigens. This was not observed in normal livers where
hepatocytes expressed hepatocyte-associated antigens and bile duct cells expressed oval
cell-associated antigens only. These same antigens were also detected in foci and
nodules, but in lesser amounts [445]. Several other studies have also shown the antigenic
properties o f both oval cells and hepatocytes in hepatocellular carcinomas and tumors
[471,475,476]. In G. affinis, these basophilic bile duct-like oval cells were the only type
of altered foci observed. While there was only one tumor observed in this study, it was a
basophilic spindle cell tumor. This is aligned with the growing evidence that
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proliferation of these oval cells and their subsequent formation of foci may be a precursor
in PHC, tumors, and nodules.
Investigations into the early proliferative state of these oval cells upon exposure to
2AAF, have revealed that although it is a regenerative process resulting from a adaptive
response to earlier cell death, this compensatory regeneration is different from those
induced by partial hepatectomy. Hepatocytes proliferating from a partial hepatectomy do
not involve intra- or extra-hepatic stem cells, only hepatocytes, while intra-hepatic
precursor cells (oval cells) proliferate and generate lineage only when hepatocyte
proliferation is blocked or delayed as seen with 2AFF [461]. 2AAF was shown to inhibit
proliferation of non-initiated hepatocytes by blocking cells in the G1 phase, suggesting a
direct toxic effect [472].

Here, significant increases in oval cell proliferation were

observed in the 2AF and BZ exposed groups. This is reflective of compensatory
proliferation of oval cells rather than normal regeneration of hepatocytes. Further
evidence of differential proliferation of cells during chemical exposure was demonstrated
in a study with 2AAF that induced a mitogenic response in ductal and nondescript
periductular cells within 24 hrs after administration. Levels o f three transcription factors
and two genes regulated by these factors were assayed and 2AAF exposed livers had
increased expression of two of the transcription factors and both o f the genes they
regulate. In contrast, the bile duct proliferation induced by bile duct ligation, did not
affect the levels o f any o f these factors assayed [462]. Therefore, based on these previous
studies, the results from arylamine exposure in G. affinis livers are closely aligned with
those in mammalians where early, reversible cell death is followed by proliferation of
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oval cells resulting in altered cellular foci of basophilic spindle/oval cell composition and
ultimately tumor formation.
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CHAPTER VI

CONCLUSIONS

A need exists for testing environmental carcinogens in small aquatic species.
Small fish species are well suited to act as sentinels for monitoring of harmful chemicals
in ponds, streams, lakes, etc. Typically aquatic ecosystems are monitored by collecting
water or sediment samples from specific sites and evaluating the samples for acute
toxicity. However, this doesn’t reflect the dynamic change occurring in aquatic
ecosystems that organisms encounter such as tide, temperature and sediment disturbance
that may modify exposure effects [477]. Additionally, the demonstrated capacity for
neoplastic development in aquatic species is useful in comparison studies for
investigating common mechanisms in carcinogenesis [29, 360,470]. For example,
exposure studies with diethylmfrosamine (DEN) have demonstrated neoplasms in
Medaka and Mangrove rivulus along with increases in the expression ofFos, Ras, Myc
and p53 cancer related genes [361,478]. Other chemicals such as MAM-Ac have
induced tumor formation in G. affinis, and 2AF and MNNG induced tumors in Fundulus
grandis [27,199]. Another aspect is the ease in housing in large numbers o f small fish
with minimal expense when compared to traditional rodent models. This is important for
both fiscal limitations and statistical significance.
Here, G. affinis was selected as the small fish species because they develop
neoplasms in response to carcinogen exposure, are geographically diverse, tolerate a wide
range o f waters from optimal to poor, reside in a localized vicinity and are easy to house
and maintain [35, 377,468,479-482]. G. affinis form neoplasms in response to the
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alkylating metabolic class of carcinogens, however more metabolic classes need to be
examined [27]. To test the utility of the G. affinis in carcinogenesis studies, molecular
tools were investigated for use in assaying the effects of exposure to the PAA metabolic
class of carcinogens. The PAA’s examined here are the much-studied 2AF and BZ.
Both azo-based dyes, o f which BZ is a component, and 2AAF, a metabolite of 2AP, exert
non-genotoxic and genotoxic effects in the livers of rodents. They inhibit the
proliferation of non-initiated hepatocytes and enhance the proliferation of oval cells.
This ultimately leads to an altered liver architecture and subsequent tumor formation
[119,445,454,457,461]. 2AF, has also been shown to induce proliferation in the small
fish species, Fundulus grandis [199].
Therefore, the molecular tools investigated here are antibodies against antigens
associated with cellular proliferation and programmed cell death. These antibodies were
tested for specificity in G. affinis. Cellular proliferation was represented by the PCNA
antibody and various stages o f apoptosis by p53 and cleaved caspase-3 and PARP
antibodies as discussed in their literature reviews. However, in order to test the
specificity o f these antibodies on G. affinis proteins, non-transformed, proliferating
hepatocytes induced to undergo apoptosis, with no or minimal necrosis, are necessary for
use as internal controls. The AML12 line o f epithelial-like proliferating hepatocytes was
tested for this purpose using camptothecin for apoptosis induction. Results from flow
cytometric analysis, fluorescence microscopy and DIG microscopy demonstrated that this
proliferating line of hepatocytes could be induced to undergo apoptosis with negligible
necrosis. This allowed for the use o f the AML12 hepatocytes as internal controls for
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western blot analysis o f PCNA, p53 and cleaved caspase-3 and PARP antibody
specificity to G. affinis.
The antibodies were tested using western blotting with protein extracts from
carbon tetrachloride treated and control G. affinis. The results of this analysis indicated
specificity of the PCNA antibody for G. affinis PCNA. Unfortunately, western blots
were inconclusive for the remaining antibodies, p53 and cleaved caspase-3 and PARP.
While the PCNA antibody is sufficient for detection o f proliferation, detection o f cellular
death would require the use of a different biomarker. Therefore, the TUNEL technique
was tested, TUNEL labels DNA strand breaks associated with apoptosis, however, it has
also been demonstrated to detect necrosis [291-294]. Testing of the TUNEL technique
was successful and was employed in this study to measure cellular death.
To test the effects of 2AF and BZ exposure on cellular proliferation and death in
G. affinis, doses o f 0.069 mM and 6.9 mM individually or combined was added in their

diets for time intervals of 4, 8 and 12 weeks. Liver tissue sections were labeled
individually with PCNA antibody, TUNEL, and H&E. Results revealed a slight transient
increase in cell death at 4 weeks that decreased in weeks 8 and 12. Cellular proliferation
was increased at all time intervals, especially by week 12. H&E staining revealed
substantially increased proliferation of basophilic oval to spindle shaped bile duct-like
cells. These same basophilic oval cells were also observed in altered areas o f cellular
foci. All treatment groups had significant increases o f the altered foci. At 8 weeks a
basophilic spindle cell tumor had formed in the low dose BZ group.
Comparisons of these results with those in mammalian studies of arylamines are
aligned and may have common mechanisms. Investigations into arylamine
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carcinogenicity have established an early increase in apoptotic and/or necrotic cell death
that decreases shortly thereafter to normal levels as was observed in G. affinis. In
rodents, this is in response to a disruption o f the biochemical homeostasis in the liver by
2AAF metabolites as evidenced by the number o f changes in carbohydrate metabolism
and oxidative phosphorylation enzyme activity levels [442,444, 457], The apoptotic
response alters the activation o f the mitochondrial permeability transition pores that
induce apoptosis. At first they are activated, and shortly thereafter, inhibited during the
early stages of 2AAF carcinogenesis [455]. In an adaptive response to the loss of cells
during this early stage, regenerative proliferation takes place. However, this regenerative
proliferation is not like the type that occurs during partial hepatectomy (PH). PH results
in the proliferation of normal hepatocytes, whereas, 2AAF results in the proliferation of
bile duct-like oval cells and the inhibition of normal hepatocyte proliferation [442,445,
454, 461], This compensatory regeneration alters the normal architecture of the liver. It
has been hypothesized that the altered architecture of the liver is a prerequisite for the
expansion of initiated foci. This is based on the proliferation of bile duct-like cells that
produce reticulin fibers and disrupt microcirculation, along with resistance of
mitochondrial permeability transition pore activation Also, an increased proportion of
GST-P-positive foci begin appearing at a time when the liver reaches a certain degree of
alteration [444,453, 455].
In summary, 2AF and BZ exposed G. affinis produce a mammalian-like response
to 2AF and BZ exposure with varying degrees of the same response. All treatment
groups had a greater proliferative response and only a transient death response that
resulted in positive net cellular growth. More oval cell proliferation, altered foci and
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tumor formation occurred in the treated groups when compared with the controls. These
results are much like the results of numerous studies o f 2AAF and azo-based dye
exposure in rodents and humans. This study further advances the potential utility of G.
affinis as an excellent sentinel species candidate for biomonitoring o f environmental

carcinogens in aquatic ecosystems. The use o f PCNA antibodies and TUNEL method are
excellent biomarkers for cellular proliferation and death. Future investigations using
varying metabolic classes of carcinogen and non-genotoxic chemical exposures to G.
affinis, will aid in the advancement of their biomonitoring potential. Additionally,
examination of cellular death at earlier time points and foci and tumor formation at later
time points will further define the carcinogenic process in this species. In retrospect, the
use of whole mounts rather than individual organs, and additional screening of molecular
tools would be beneficial in future toxicology and carcinogenesis studies with G, affinis.
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Individual TUNEL Index, PCNA Index and (PI - TI) Index Counts
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Time and
Treatment
4N
4N
4N
4N
4N
4N
4N
4E
4E
4E
4E
4E
4E
4E
4AL
4AL
4AL
4AL
4AL
4AL
4AL
4AH
4AH
4AH
4AH
4AH
4AH
4AH
4BL
4BL
4BL
4BL
4BL
4BL
4BL
4BH
4BH
4BH
4BH
4BH
4BH
4BH

TUNEL
Index
0
6
2
2
0
1
2

0
2
2
0
1
1
0
15
1
1
73
1
1
15
2
2
1
0
3
5
10
4
3
17
1
0
12
8
41
1
0
0
3
3
0

PCNA
Index
0
6
0
0
3
0
2
1
9
4
0
3
19
1
0
14
5
55
2
11
13
9
101
1
22
4
6
24
33
25
28
141
156
63
178
3
66
22
45

12
16
23

(PI - TI)
Index
0
0
-2
-2
3
-1
0
1
7
2
0
2
18
1
-15
13
4
-18
1
10
-2
7
99
0
22
1
1
14
29
22
11
140
156
51
170
-38
65
22
45
9
13
23

Time a id
Treatment
4ABL
4ABL
4ABL
4ABL
4ABL
4ABL
4ABL
4ABH
4ABH
4ABH
4ABH
4ABH
4ABH
4ABH
8N
8N
8N
8N
8N
8N
8N
8E
8E
8E
8E
8E
8E
BE
SAL
SAL
8AL
8AL
8AL
SAL
SAL
8AH
8AH
8AH
8AH
8AH
8AH
8AH

TUNEL
Index
0
1
2
3
I
1
14
2
0
1
0
1
7
3
0
10
14
4
0
0
1
6
13
1
1
1
5
5
7
5
1
4
1
0
3
1
1
1
1
2
6
2

PCNA
Index
7
54
22
22
3
41
4
12
13
9
15
29
22
9
0
2
4
2
3
3
19
2
26
6
0
12
36
14
39
4
18
9
25
4
17
21
22
15
7
18
12
18

(PI - TI)
Index
7
53
20
19
2
40
-10
10
13
8
15
28
15
6
0
-8
-10
-2
3
3
18
-4
13
5
-1
11
31
9
32
-1
17
5
24
4
14
20
21
14
6
16
6
16
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Time and
Treatment
8BL
8BL
8BL
8BL
8BL
8BL
8BL
8BH
8BB
8BH
8BH
8BH
8BH
8BH
8ABL
8ABL
8ABL
8ABL
8ABL
8ABL
8ABL
8ABH
8ABH
8ABH
8ABH
8ABH
8ABH
8ABH
12N
12N
12N
12N
12N
12N
12N
12E
12E
12E
12E
12E
12E
12E

TUNEL
Index
5
2
4
4
5
3
3
4
0
0
4
1

3
3
1
1
0
5
0
3
I
1
0
1
2
3
0
5
3
3
1
1
2
0
4
4
3
2
2
2
2
2

PCNA
Index
37
18
20
7
10
1
0
13
52
27
10
14
12
8
17
54
135
5
58
42
11
8
12
21
11
4
42
8
40
31
12
18
8
0
18
17
7
14
3
0
7
7

(P I-T I)
Index
32
16
16
3
5
-2
-3
9
52
27
6
13
9
5
16
53
135
0
58
39
10
1

12
20
9
1
42
3
37
28
11
17
6
0
14
13
4
12
1
-2
5
5

Time and
Treatment
12AL
12AJL
12AJL
12AL
12AL
12AL
12AL
12AH
12AH
12AH
12AH
12AH
12AH
12AH
12BL
12BL
12BL
12BL
12BL
12BL
12BL
12BH
12BH
12BH
12BH
12BH
12BH
12BH
12ABL
12ABL
12ABL
12ABL
12ABL
12ABL
12ABL
12ABH
12ABH
12ABH
12ABH
12ABH
12ABH
12ABH

TUNEL
Index
1
0
0
0
7
0
1
0
0
1
2
2
3
1
2
5
5
2
0
1
2
3
0
2
0
2
0
4
8
3
4
3
1
0
2
1
1
1
2
5
0
2

PCNA
Index
5
11
30
118
26
10
33
79
164
58
35
11
60
68
13
33
7
22
94
27
24
43
81
49
38
17
2
10
21
37
51
69
30
15
37
15
6
96
37
39
36
38

(PI - TI)
Index
4
11
30
118
19
10
32
79
164
57
33
9
57
67
11
28
2
20
94
26
22
40
81
47
38
15
2
6
13
34
47
66
29
15
35
14
5
95
35
34
36
36
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